Tissue-specific	O
expression	O
of	O
the	O
platelet	B-DNA
GPIIb	I-DNA
gene	I-DNA
.	O

One	O
of	O
the	O
major	O
objectives	O
in	O
the	O
study	O
of	O
thrombogenesis	O
is	O
to	O
determine	O
the	O
mechanisms	O
by	O
which	O
a	O
hematopoietic	B-cell_type
progenitor	I-cell_type
is	O
activated	O
and	O
committed	O
to	O
the	O
megakaryocytic	B-cell_type
lineage	I-cell_type
.	O

Recent	O
development	O
of	O
primary	B-cell_line
cultures	I-cell_line
of	O
human	B-cell_line
megakaryocytes	I-cell_line
and	O
the	O
molecular	O
cloning	O
of	O
genes	O
that	O
are	O
specific	O
to	O
this	O
lineage	O
offer	O
the	O
possibility	O
of	O
getting	O
some	O
insights	O
into	O
the	O
genetic	O
mechanisms	O
that	O
control	O
megakaryocytopoiesis	O
.	O

One	O
gene	O
of	O
interest	O
is	O
the	O
glycoprotein	B-DNA
IIb	I-DNA
(	I-DNA
GPIIb	I-DNA
)	I-DNA
gene	I-DNA
;	O
GPIIb	B-DNA
,	O
the	O
alpha	B-protein
subunit	I-protein
of	O
the	O
platelet	B-protein
cytoadhesin	I-protein
GPIIb-IIIa	I-protein
,	O
is	O
produced	O
in	O
megakaryocytes	B-cell_line
at	O
an	O
early	O
stage	O
of	O
the	O
differentiation	O
,	O
whereas	O
the	O
other	O
subunit	O
of	O
this	O
complex	O
,	O
GPIIIa	B-protein
,	O
is	O
expressed	O
in	O
other	O
cells	O
.	O

For	O
these	O
reasons	O
,	O
the	O
5'-flanking	B-DNA
region	I-DNA
of	O
the	O
GPIIb	B-DNA
gene	I-DNA
was	O
used	O
to	O
identify	O
the	O
regions	O
that	O
interact	O
with	O
DNA-binding	B-protein
nuclear	I-protein
factors	I-protein
.	O

A	O
fragment	O
extending	O
from	O
-643	B-DNA
to	I-DNA
+33	I-DNA
is	O
capable	O
of	O
controlling	O
the	O
tissue-specific	O
expression	O
of	O
the	O
CAT	B-DNA
gene	I-DNA
in	O
transfection	O
experiments	O
.	O

Within	O
this	O
region	O
,	O
we	O
have	O
identified	O
several	O
sequences	O
that	O
are	O
implicated	O
in	O
DNA	O
protein	O
interactions	O
as	O
shown	O
in	O
DNAse	B-protein
I	I-protein
footprints	O
and	O
gel	O
mobility	O
shift	O
assays	O
.	O

One	O
region	O
,	O
centered	O
at	O
-54	O
,	O
is	O
similar	O
to	O
a	O
nuclear	B-DNA
factor	I-DNA
E1-binding	I-DNA
site	I-DNA
,	O
and	O
a	O
region	O
located	O
at	O
position	O
-233	O
contains	O
a	O
CCAAT	B-DNA
motif	I-DNA
.	O

Two	O
domains	O
centered	O
at	O
positions	O
-345	O
and	O
-540	O
,	O
respectively	O
,	O
bind	O
proteins	O
that	O
are	O
present	O
in	O
megakaryocytic	B-cell_line
cells	I-cell_line
and	O
nonrelated	B-cell_type
cells	I-cell_type
as	O
well	O
.	O

Finally	O
,	O
two	O
other	O
domains	O
,	O
located	O
at	O
positions	O
-460	O
and	O
-510	O
,	O
interact	O
with	O
proteins	O
that	O
are	O
only	O
present	O
in	O
megakaryocytic	B-cell_line
cells	I-cell_line
.	O

In	O
addition	O
,	O
deletion	O
of	O
the	O
region	O
containing	O
these	O
two	O
domains	O
results	O
in	O
a	O
significant	O
decrease	O
of	O
the	O
promoter	B-DNA
activity	O
.	O

It	O
is	O
very	O
likely	O
that	O
these	O
domains	O
bind	O
megakaryocyte-specific	B-protein
nuclear	I-protein
proteins	I-protein
acting	O
as	O
positive	B-protein
transcription	I-protein
factors	I-protein
.	O

THE	NULL
JournaL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1991	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

266	NULL
,	NULL
No	NULL
.	NULL

14	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

8932-8939	NULL
,	NULL
1991	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Tissue-specific	NULL
Expression	NULL
of	NULL
the	NULL
Platelet	NULL
GPIIb	NULL
Gene*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
8	NULL
,	NULL
1991	NULL
)	NULL
Georges	NULL
Uzan	NULL
,	NULL
Michel	NULL
Prenant	NULL
,	NULL
Marie-Héléene	NULL
Prandini	NULL
,	NULL
Florence	NULL
Martin	NULL
,	NULL
and	NULL
Gérard	NULL
Marguerie	NULL
From	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
U217	NULL
,	NULL
Laboratoire	NULL
d'Hématologie	NULL
,	NULL
Departement	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
et	NULL
Structurale	NULL
,	NULL
Centre	NULL
d'Etudes	NULL
Nucléaires	NULL
,	NULL
38041	NULL
Grenoble	NULL
,	NULL
France	NULL
One	NULL
of	NULL
the	NULL
major	NULL
objectives	NULL
in	NULL
the	NULL
study	NULL
of	NULL
thrombo-genesis	NULL
is	NULL
to	NULL
determine	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
a	NULL
hematopoietic	NULL
progenitor	NULL
is	NULL
activated	NULL
and	NULL
committed	NULL
to	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
.	NULL

Recent	NULL
development	NULL
of	NULL
primary	NULL
cultures	NULL
of	NULL
human	NULL
megakaryocytes	NULL
and	NULL
the	NULL
molecular	NULL
cloning	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
specific	NULL
to	NULL
this	NULL
lineage	NULL
offer	NULL
the	NULL
possibility	NULL
of	NULL
getting	NULL
some	NULL
insights	NULL
into	NULL
the	NULL
genetic	NULL
mechanisms	NULL
that	NULL
control	NULL
megakaryocytopoiesis	NULL
.	NULL

One	NULL
gene	NULL
of	NULL
interest	NULL
is	NULL
the	NULL
glycoprotein	NULL
IIb	NULL
(	NULL
GPIIb	NULL
)	NULL
gene	NULL
;	NULL
GPIIb	NULL
,	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
platelet	NULL
cytoadhesin	NULL
GPIIb-IIIa	NULL
,	NULL
is	NULL
produced	NULL
in	NULL
megakaryocytes	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
of	NULL
the	NULL
differentiation	NULL
,	NULL
whereas	NULL
the	NULL
other	NULL
subunit	NULL
of	NULL
this	NULL
complex	NULL
,	NULL
GPIIIa	NULL
,	NULL
is	NULL
expressed	NULL
in	NULL
other	NULL
cells	NULL
.	NULL

For	NULL
these	NULL
reasons	NULL
,	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
GP	NULL
IIb	NULL
gene	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
regions	NULL
that	NULL
interact	NULL
with	NULL
DNA-binding	NULL
nuclear	NULL
factors	NULL
.	NULL

A	NULL
fragment	NULL
extending	NULL
from	NULL
-643	NULL
to	NULL
+33	NULL
is	NULL
capable	NULL
of	NULL
controlling	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
in	NULL
transfection	NULL
experiments	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
several	NULL
sequences	NULL
that	NULL
are	NULL
implicated	NULL
in	NULL
DNA	NULL
protein	NULL
interactions	NULL
as	NULL
shown	NULL
in	NULL
DNAse	NULL
I	NULL
footprints	NULL
and	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

One	NULL
region	NULL
,	NULL
centered	NULL
at	NULL
-54	NULL
,	NULL
is	NULL
similar	NULL
to	NULL
a	NULL
nuclear	NULL
factor	NULL
El-binding	NULL
site	NULL
,	NULL
and	NULL
a	NULL
region	NULL
located	NULL
at	NULL
position	NULL
-233	NULL
contains	NULL
a	NULL
CCAAT	NULL
motif	NULL
.	NULL

Two	NULL
domains	NULL
centered	NULL
at	NULL
positions	NULL
-345	NULL
and	NULL
-540	NULL
,	NULL
respectively	NULL
,	NULL
bind	NULL
proteins	NULL
that	NULL
are	NULL
present	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
and	NULL
nonrelated	NULL
cells	NULL
as	NULL
well	NULL
.	NULL

Finally	NULL
,	NULL
two	NULL
other	NULL
domains	NULL
,	NULL
located	NULL
at	NULL
positions	NULL
-460	NULL
and	NULL
-510	NULL
,	NULL
interact	NULL
with	NULL
proteins	NULL
that	NULL
are	NULL
only	NULL
present	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
region	NULL
containing	NULL
these	NULL
two	NULL
domains	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
very	NULL
likely	NULL
that	NULL
these	NULL
domains	NULL
bind	NULL
megakaryocyte-specific	NULL
nuclear	NULL
proteins	NULL
acting	NULL
as	NULL
positive	NULL
transcription	NULL
factors	NULL
.	NULL

A	NULL
central	NULL
objective	NULL
in	NULL
hematopoiesis	NULL
is	NULL
to	NULL
identify	NULL
the	NULL
factors	NULL
that	NULL
control	NULL
the	NULL
commitment	NULL
of	NULL
a	NULL
progenitor	NULL
cell	NULL
to	NULL
a	NULL
specific	NULL
lineage	NULL
.	NULL

Over	NULL
the	NULL
past	NULL
decade	NULL
,	NULL
remarkable	NULL
progress	NULL
has	NULL
been	NULL
made	NULL
concerning	NULL
the	NULL
role	NULL
of	NULL
hematopoietic	NULL
factors	NULL
and	NULL
oncogene	NULL
products	NULL
in	NULL
the	NULL
differentiation	NULL
or	NULL
proliferation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
that	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
differentiation	NULL
process	NULL
.	NULL

Within	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
is	NULL
difficult	NULL
to	NULL
study	NULL
because	NULL
megakaryocytes	NULL
represent	NULL
a	NULL
very	NULL
small	NULL
percentage	NULL
of	NULL
the	NULL
total	NULL
marrow	NULL
cells	NULL
.	NULL

With	NULL
the	NULL
recent	NULL
develop	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
and	NULL
Commissariat	NULL
a	NULL
l'Energie	NULL
Atomique	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

ment	NULL
of	NULL
liquid	NULL
culture	NULL
of	NULL
human	NULL
megakaryocytes	NULL
(	NULL
2	NULL
)	NULL
,	NULL
clonal	NULL
cultures	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
characterization	NULL
of	NULL
an	NULL
increasing	NULL
number	NULL
of	NULL
permanent	NULL
cell	NULL
lines	NULL
with	NULL
defined	NULL
megakaryocytic	NULL
features	NULL
(	NULL
5-8	NULL
)	NULL
,	NULL
analysis	NULL
of	NULL
megakaryocytopoiesis	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
now	NULL
becomes	NULL
feasible	NULL
.	NULL

One	NULL
way	NULL
to	NULL
approach	NULL
this	NULL
question	NULL
is	NULL
to	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
marker	NULL
gene	NULL
that	NULL
is	NULL
both	NULL
highly	NULL
specific	NULL
to	NULL
the	NULL
lineage	NULL
and	NULL
expressed	NULL
at	NULL
an	NULL
early	NULL
step	NULL
during	NULL
the	NULL
differentiation	NULL
process	NULL
.	NULL

The	NULL
gene	NULL
coding	NULL
for	NULL
the	NULL
platelet	NULL
glycoprotein	NULL
IIb	NULL
appears	NULL
to	NULL
fulfill	NULL
these	NULL
crite-ria	NULL
.	NULL

GPIIb	NULL
'	NULL
is	NULL
the	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
platelet	NULL
RGD-sensitive	NULL
integrin	NULL
GPIIb-IIIa	NULL
,	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
specific	NULL
receptor	NULL
for	NULL
fibrinogen	NULL
,	NULL
fibronectin	NULL
,	NULL
and	NULL
von	NULL
Willebrand	NULL
's	NULL
factor	NULL
(	NULL
9-13	NULL
)	NULL
.	NULL

While	NULL
the	NULL
8	NULL
subunit	NULL
(	NULL
GPIHHa	NULL
)	NULL
of	NULL
this	NULL
integrin	NULL
is	NULL
expressed	NULL
in	NULL
different	NULL
cells	NULL
,	NULL
including	NULL
megakaryocytes	NULL
(	NULL
14	NULL
)	NULL
,	NULL
endothelial	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
,	NULL
macrophages	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
,	NULL
and	NULL
fibroblastic	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
,	NULL
the	NULL
GP	NULL
IIb	NULL
mRNA	NULL
seems	NULL
to	NULL
be	NULL
produced	NULL
only	NULL
in	NULL
megakaryocytes	NULL
.	NULL

The	NULL
protein	NULL
is	NULL
synthesized	NULL
as	NULL
a	NULL
precursor	NULL
,	NULL
and	NULL
its	NULL
processing	NULL
is	NULL
controlled	NULL
by	NULL
an	NULL
early	NULL
assembly	NULL
with	NULL
GPIIIa	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Different	NULL
reports	NULL
from	NULL
independent	NULL
groups	NULL
have	NULL
suggested	NULL
that	NULL
GPIIb	NULL
is	NULL
an	NULL
early	NULL
marker	NULL
for	NULL
megakaryocytopoiesis	NULL
.	NULL

Rabellino	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
have	NULL
initially	NULL
reported	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IIb-IIla	NULL
complex	NULL
in	NULL
early	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

Based	NULL
on	NULL
cytotoxicity	NULL
experiments	NULL
,	NULL
Berridge	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
and	NULL
Fraser	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
GPIIb	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
murine	NULL
and	NULL
the	NULL
human	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
.	NULL

Using	NULL
the	NULL
same	NULL
approach	NULL
,	NULL
Levene	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
have	NULL
concluded	NULL
that	NULL
GPIIb-IIIa	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
colony-forming	NULL
unit	NULL
megakaryocyte	NULL
.	NULL

These	NULL
conclusions	NULL
were	NULL
,	NULL
however	NULL
,	NULL
more	NULL
recently	NULL
challenged	NULL
by	NULL
Kanz	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
immunologic	NULL
labeling	NULL
and	NULL
cell	NULL
sorting	NULL
,	NULL
these	NULL
authors	NULL
have	NULL
concluded	NULL
that	NULL
the	NULL
8	NULL
subunit	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
GPIIIa	NULL
,	NULL
is	NULL
not	NULL
present	NULL
in	NULL
the	NULL
progenitor	NULL
cells	NULL
.	NULL

It	NULL
may	NULL
,	NULL
however	NULL
,	NULL
be	NULL
argued	NULL
that	NULL
flow	NULL
cytom-etry	NULL
is	NULL
a	NULL
less	NULL
sensitive	NULL
method	NULL
than	NULL
cytotoxicity	NULL
at	NULL
detecting	NULL
surface-exposed	NULL
glycoproteins	NULL
.	NULL

Nevertheless	NULL
,	NULL
there	NULL
is	NULL
ample	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
GP	NULL
IIb	NULL
is	NULL
an	NULL
early	NULL
and	NULL
specific	NULL
marker	NULL
for	NULL
megakaryocytopoiesis	NULL
.	NULL

We	NULL
have	NULL
obtained	NULL
cDNA	NULL
clones	NULL
containing	NULL
the	NULL
complete	NULL
sequence	NULL
of	NULL
GPIIb	NULL
from	NULL
human	NULL
megakaryocyte	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
and	NULL
isolated	NULL
the	NULL
gene	NULL
encoding	NULL
this	NULL
protein	NULL
(	NULL
28	NULL
)	NULL
.	NULL

This	NULL
gene	NULL
spans	NULL
a	NULL
region	NULL
of	NULL
17.2	NULL
kb	NULL
(	NULL
29	NULL
)	NULL
and	NULL
is	NULL
located	NULL
on	NULL
chromosome	NULL
17	NULL
at	NULL
position	NULL
q21-23	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
this	NULL
gene	NULL
contains	NULL
positive	NULL
responsive	NULL
elements	NULL
for	NULL
a	NULL
tissue-specific	NULL
expression	NULL
and	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
specific	NULL
and	NULL
ubiquitous	NULL
nuclear	NULL
proteins	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GP	NULL
,	NULL
glycoprotein	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
NF-E1	NULL
,	NULL
nuclear	NULL
factor	NULL
El	NULL
;	NULL
HEPES	NULL
,	NULL
4-	NULL
(	NULL
2-hydroxy-ethyl	NULL
)	NULL
-1-piperazineethanesulfonic	NULL
acid	NULL
;	NULL
EGTA	NULL
,	NULL
[	NULL
ethylenebis	NULL
(	NULL
oxy-ethylenenitrilo	NULL
)	NULL
]	NULL
tetraacetic	NULL
acid	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
.	NULL

8932	NULL
Expression	NULL
of	NULL
Platelet	NULL
GP	NULL
IIb	NULL
Gene	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
DNA	NULL
Probes-A	NULL
1.9-kb	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
transcription	NULL
initiation	NULL
start	NULL
site	NULL
and	NULL
1.6	NULL
kb	NULL
of	NULL
the	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
GPIIb	NULL
gene	NULL
was	NULL
subcloned	NULL
in	NULL
the	NULL
PGEM.1	NULL
plasmid	NULL
(	NULL
28	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
further	NULL
digested	NULL
with	NULL
Mbol	NULL
to	NULL
generate	NULL
a	NULL
Mbol-Mbol	NULL
segment	NULL
containing	NULL
the	NULL
genomic	NULL
sequence	NULL
from	NULL
nucleotide	NULL
+33	NULL
to	NULL
-1040	NULL
.	NULL

All	NULL
the	NULL
other	NULL
DNA	NULL
fragments	NULL
for	NULL
DNase	NULL
I-footprinting	NULL
assays	NULL
were	NULL
derived	NULL
from	NULL
this	NULL
1.08-kb	NULL
fragment	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

Each	NULL
PCR	NULL
fragment	NULL
was	NULL
sequenced	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
*P	NULL
]	NULL
ATP	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
cut	NULL
with	NULL
selected	NULL
restriction	NULL
enzymes	NULL
to	NULL
generate	NULL
one	NULL
end-labeled	NULL
fragment	NULL
,	NULL
and	NULL
isolated	NULL
.	NULL

The	NULL
synthetic	NULL
oligonucleotides	NULL
used	NULL
in	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
prepared	NULL
with	NULL
an	NULL
Applied	NULL
Biosystem	NULL
DNA	NULL
synthesizer	NULL
.	NULL

The	NULL
first	NULL
strand	NULL
was	NULL
5	NULL
end-labeled	NULL
and	NULL
annealed	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
nonlabeled	NULL
second	NULL
strand	NULL
at	NULL
a	NULL
1:4	NULL
ratio	NULL
to	NULL
optimize	NULL
annealing	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

The	NULL
CAAT	NULL
-binding	NULL
site	NULL
from	NULL
the	NULL
«	NULL
-globin	NULL
gene	NULL
was	NULL
5-TCCGCGCCAGCCAATGAG-3	NULL
'	NULL
(	NULL
32	NULL
)	NULL
;	NULL
the	NULL
HNF1-binding	NULL
site	NULL
from	NULL
the	NULL
fibrinogen	NULL
$	NULL
gene	NULL
was	NULL
5'-GATCT-CAAATGT	NULL
CAAATATTAACTAAAGGGAG-3	NULL
'	NULL
(	NULL
33	NULL
)	NULL
;	NULL
the	NULL
consensus	NULL
spl-binding	NULL
site	NULL
from	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
was	NULL
5'-TAGTCCCGCCCCTAAC	NULL
TCCGCCCATCCCG-3	NULL
'	NULL
(	NULL
34	NULL
)	NULL
;	NULL
and	NULL
the	NULL
NF-El-binding	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
a-globin	NULL
gene	NULL
was	NULL
5-GATCTCCGGGCAACTGATAAGGATTCCCTG-3	NULL
'	NULL
(	NULL
35	NULL
)	NULL
.	NULL

All	NULL
the	NULL
fragments	NULL
were	NULL
verified	NULL
on	NULL
acrylamide	NULL
gels	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
concentration	NULL
was	NULL
established	NULL
by	NULL
comparison	NULL
with	NULL
digested	NULL
E.	NULL
coli	NULL
DNA	NULL
and	NULL
optical	NULL
density	NULL
measurement	NULL
at	NULL
260	NULL
nm	NULL
.	NULL

Cells	NULL
and	NULL
Nuclear	NULL
Extracts-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
following	NULL
cells	NULL
:	NULL
HeLa	NULL
,	NULL
HEL	NULL
,	NULL
Raji	NULL
,	NULL
U937	NULL
,	NULL
HL60	NULL
,	NULL
and	NULL
human	NULL
megakaryocytes	NULL
.	NULL

All	NULL
the	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
for	NULL
24	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Human	NULL
megakaryocytes	NULL
were	NULL
isolated	NULL
and	NULL
cultured	NULL
for	NULL
10	NULL
days	NULL
according	NULL
to	NULL
the	NULL
method	NULL
previously	NULL
described	NULL
in	NULL
detail	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
rapid	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
0.5-1	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
rinsed	NULL
twice	NULL
in	NULL
TBS	NULL
(	NULL
Tris	NULL
buffer	NULL
saline	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
harvested	NULL
15	NULL
s	NULL
in	NULL
a	NULL
microcentrifuge	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
400	NULL
ul	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.1	NULL
mm	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

Following	NULL
15	NULL
min	NULL
of	NULL
incubation	NULL
,	NULL
15	NULL
ul	NULL
of	NULL
a	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
solution	NULL
were	NULL
added	NULL
at	NULL
4	NULL
°C	NULL
and	NULL
vigorously	NULL
homogenized	NULL
.	NULL

After	NULL
30	NULL
s	NULL
of	NULL
high	NULL
speed	NULL
centrifugation	NULL
in	NULL
the	NULL
microcentrifuge	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
discarded	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
cold	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
.	NULL

After	NULL
clarification	NULL
using	NULL
high	NULL
speed	NULL
centrifugation	NULL
,	NULL
aliquots	NULL
were	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
in	NULL
buffer	NULL
B.	NULL
Gel	NULL
Retardation	NULL
Assays-The	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
procedures	NULL
of	NULL
Halligan	NULL
and	NULL
Desiderio	NULL
(	NULL
37	NULL
)	NULL
and	NULL
of	NULL
Singh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
.	NULL

For	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
0.2-0.5	NULL
ng	NULL
of	NULL
radiolabeled	NULL
DNA	NULL
fragment	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
2-5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
30	NULL
pl	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
25-100	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
15	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
1-5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
)	NULL
-poly	NULL
(	NULL
dC	NULL
)	NULL
used	NULL
as	NULL
nonspecific	NULL
competitor	NULL
.	NULL

Specific	NULL
competitors	NULL
were	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
as	NULL
described	NULL
in	NULL
the	NULL
individual	NULL
experiments	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
analyzed	NULL
on	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
buffer	NULL
(	NULL
1	NULL
x	NULL
TBE	NULL
:	NULL
0.089	NULL
m	NULL
Tris-HCl	NULL
,	NULL
0.089	NULL
M	NULL
boric	NULL
acid	NULL
,	NULL
0.002	NULL
M	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
preelectrophoresed	NULL
twice	NULL
at	NULL
180	NULL
V	NULL
for	NULL
1	NULL
h	NULL
and	NULL
electrophoresed	NULL
at	NULL
the	NULL
same	NULL
voltage	NULL
for	NULL
2-3	NULL
h	NULL
at	NULL
+4	NULL
°C	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
the	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
autoradiographed	NULL
overnight	NULL
.	NULL

DNase	NULL
I	NULL
Protection	NULL
Assays-The	NULL
footprinting	NULL
studies	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Ohlsson	NULL
and	NULL
Edlund	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
)	NULL
-poly	NULL
(	NULL
dC	NULL
)	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
containing	NULL
25	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.05	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

Two	NULL
ng	NULL
of	NULL
5	NULL
end-labeled	NULL
DNA	NULL
fragment	NULL
(	NULL
30,000	NULL
cpm	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
allowed	NULL
for	NULL
40	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Three	NULL
to	NULL
four	NULL
units	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
were	NULL
then	NULL
added	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
mM	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
and	NULL
digestion	NULL
was	NULL
allowed	NULL
for	NULL
1	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
enzyme	NULL
was	NULL
inactivated	NULL
with	NULL
100	NULL
pl	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
100	NULL
gM	NULL
Tris	NULL
hydrochloride	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
proteinase	NULL
K/ml	NULL
,	NULL
and	NULL
25	NULL
ug	NULL
of	NULL
tRNA/	NULL
ml	NULL
and	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
followed	NULL
by	NULL
phenol	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

The	NULL
one-end-labeled	NULL
DNA	NULL
fragments	NULL
were	NULL
analyzed	NULL
on	NULL
denaturing	NULL
6-8	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
fixed	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Cell	NULL
Transfection	NULL
and	NULL
CAT	NULL
Assays-The	NULL
chloramphenicol	NULL
acetyl-	NULL
8933	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
plasmid	NULL
used	NULL
was	NULL
pBLCAT3	NULL
(	NULL
40	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
and	NULL
the	NULL
polyadenylation	NULL
signal	NULL
from	NULL
SV40	NULL
.	NULL

The	NULL
1.08-kb	NULL
Mbol/Mbol	NULL
genomic	NULL
segment	NULL
was	NULL
blunted	NULL
and	NULL
inserted	NULL
to	NULL
the	NULL
Xba-I	NULL
site	NULL
of	NULL
pBLCAT3	NULL
.	NULL

This	NULL
construction	NULL
was	NULL
linearized	NULL
with	NULL
Sph-I	NULL
and	NULL
Sal-I	NULL
and	NULL
digested	NULL
progressively	NULL
with	NULL
Exoll	NULL
!	NULL

mung	NULL
bean	NULL
nuclease	NULL
.	NULL

Three	NULL
fragments	NULL
were	NULL
selected	NULL
extending	NULL
from	NULL
+33	NULL
to	NULL
-414	NULL
,	NULL
-553	NULL
,	NULL
and	NULL
-643	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
constructions	NULL
were	NULL
transfected	NULL
into	NULL
HEL	NULL
and	NULL
Raji	NULL
cells	NULL
by	NULL
the	NULL
electroporation	NULL
method	NULL
(	NULL
41	NULL
)	NULL
and	NULL
into	NULL
HeLa	NULL
cells	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
pRSVCAT	NULL
plasmid	NULL
containing	NULL
the	NULL
CAT	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
RSV	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
pRSVL	NULL
plasmid	NULL
,	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
RSV	NULL
promoter	NULL
(	NULL
43	NULL
)	NULL
,	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
IIb	NULL
CAT	NULL
constructs	NULL
for	NULL
internal	NULL
control	NULL
.	NULL

After	NULL
each	NULL
transfection	NULL
,	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
luminometer	NULL
and	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
.	NULL

To	NULL
normalize	NULL
the	NULL
different	NULL
experiments	NULL
with	NULL
the	NULL
pBLIIb	NULL
CAT	NULL
construct	NULL
,	NULL
an	NULL
amount	NULL
protein	NULL
extract	NULL
corresponding	NULL
to	NULL
20	NULL
luciferase	NULL
units	NULL
was	NULL
used	NULL
for	NULL
the	NULL
CAT	NULL
assays	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
high	NULL
activity	NULL
of	NULL
the	NULL
RSV	NULL
promoter	NULL
a	NULL
lower	NULL
amount	NULL
of	NULL
protein	NULL
extract	NULL
corresponding	NULL
to	NULL
5	NULL
units	NULL
of	NULL
luciferase	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
the	NULL
CAT	NULL
assays	NULL
when	NULL
the	NULL
pRSVCAT	NULL
plasmid	NULL
was	NULL
used	NULL
in	NULL
control	NULL
experiment	NULL
.	NULL

The	NULL
correct	NULL
initiation	NULL
of	NULL
the	NULL
GPIIb	NULL
CAT	NULL
mRNA	NULL
was	NULL
verified	NULL
as	NULL
follows	NULL
.	NULL

Three	NULL
different	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
and	NULL
used	NULL
in	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Oligo	NULL
1	NULL
corresponded	NULL
to	NULL
the	NULL
nucleotide	NULL
sequence	NULL
+183	NULL
to	NULL
+163	NULL
downstream	NULL
from	NULL
the	NULL
GP	NULL
IIb	NULL
transcription	NULL
start	NULL
site	NULL
;	NULL
oligo	NULL
2	NULL
contained	NULL
the	NULL
nucleotide	NULL
sequence	NULL
between	NULL
+1	NULL
and	NULL
+20	NULL
;	NULL
and	NULL
oligo	NULL
3	NULL
corresponded	NULL
to	NULL
the	NULL
sequence	NULL
between	NULL
nucleotides	NULL
-1	NULL
and	NULL
-20	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
isolated	NULL
from	NULL
the	NULL
cells	NULL
,	NULL
previously	NULL
transfected	NULL
with	NULL
the	NULL
IIb	NULL
CAT	NULL
plasmid	NULL
,	NULL
were	NULL
treated	NULL
with	NULL
RQ1	NULL
DNase	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
100	NULL
pmol	NULL
of	NULL
oligo	NULL
1	NULL
and	NULL
100	NULL
pmol	NULL
of	NULL
oligo	NULL
2	NULL
or	NULL
oligo	NULL
3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
RNasin	NULL
,	NULL
200	NULL
units	NULL
of	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
)	NULL
,	NULL
2.5	NULL
units	NULL
of	NULL
Taq	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
Instruments	NULL
)	NULL
in	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
1	NULL
mM	NULL
0.01	NULL
%	NULL
gelatin	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
ul	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
heated	NULL
at	NULL
94	NULL
°C	NULL
for	NULL
1.5	NULL
min	NULL
and	NULL
subjected	NULL
to	NULL
20	NULL
cycles	NULL
of	NULL
1	NULL
min	NULL
at	NULL
94	NULL
°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
55	NULL
°C	NULL
,	NULL
and	NULL
1	NULL
min	NULL
at	NULL
72°C	NULL
in	NULL
an	NULL
automatic	NULL
thermal	NULL
cycler	NULL
.	NULL

The	NULL
amplified	NULL
DNA	NULL
was	NULL
analyzed	NULL
on	NULL
1.5	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
transferred	NULL
on	NULL
Hybond	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
genomic	NULL
probe	NULL
.	NULL

The	NULL
plasmid	NULL
Ib	NULL
CAT	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

RESULTS	NULL
A	NULL
676-bp	NULL
Fragment	NULL
from	NULL
the	NULL
5	NULL
Region	NULL
of	NULL
the	NULL
GPIIb	NULL
Gene	NULL
Contains	NULL
Sufficient	NULL
Information	NULL
for	NULL
Cell-specific	NULL
Expression-We	NULL
have	NULL
previously	NULL
reported	NULL
the	NULL
isolation	NULL
and	NULL
the	NULL
sequencing	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
and	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
start	NULL
site	NULL
of	NULL
the	NULL
human	NULL
GPIIb	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
if	NULL
this	NULL
region	NULL
contains	NULL
responsive	NULL
elements	NULL
essential	NULL
for	NULL
its	NULL
expression	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
,	NULL
a	NULL
676-bp	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
region	NULL
upstream	NULL
from	NULL
the	NULL
ATG	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
capacity	NULL
to	NULL
stimulate	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
heterologous	NULL
gene	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
in	NULL
the	NULL
vector	NULL
pBLCAT3	NULL
to	NULL
generate	NULL
the	NULL
plasmid	NULL
pBLIIbCAT3	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
we	NULL
verified	NULL
that	NULL
the	NULL
GPIIb	NULL
CAT	NULL
fusion	NULL
mRNA	NULL
was	NULL
correctly	NULL
initiated	NULL
at	NULL
the	NULL
GP	NULL
IIb	NULL
gene	NULL
initiation	NULL
start	NULL
site	NULL
.	NULL

After	NULL
transfection	NULL
with	NULL
the	NULL
IIbCAT	NULL
plasmid	NULL
,	NULL
the	NULL
RNA	NULL
were	NULL
isolated	NULL
and	NULL
amplified	NULL
with	NULL
the	NULL
PCR	NULL
methodology	NULL
using	NULL
three	NULL
different	NULL
oligonucleotides	NULL
.	NULL

Oligo	NULL
1	NULL
contained	NULL
20	NULL
nucleotides	NULL
starting	NULL
at	NULL
position	NULL
+183	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Oligos	NULL
2	NULL
and	NULL
3	NULL
contained	NULL
the	NULL
20	NULL
nucleotides	NULL
on	NULL
each	NULL
side	NULL
of	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
of	NULL
the	NULL
IIb	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
reaction	NULL
was	NULL
performed	NULL
with	NULL
oligo	NULL
1	NULL
and	NULL
oligo	NULL
2	NULL
or	NULL
3	NULL
.	NULL

When	NULL
the	NULL
IIb	NULL
CAT	NULL
plasmid	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
,	NULL
two	NULL
DNA	NULL
fragments	NULL
of	NULL
183	NULL
and	NULL
203	NULL
bp	NULL
were	NULL
generated	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
size	NULL
of	NULL
the	NULL
expected	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

When	NULL
the	NULL
mRNA	NULL
of	NULL
transfected	NULL
cells	NULL
was	NULL
used	NULL
,	NULL
a	NULL
single	NULL
fragment	NULL
of	NULL
183	NULL
bp	NULL
was	NULL
generated	NULL
with	NULL
oligos	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
the	NULL
fusion	NULL
mRNA	NULL
was	NULL
initiated	NULL
at	NULL
the	NULL
correct	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
the	NULL
GPIIb	NULL
gene	NULL
.	NULL

To	NULL
monitor	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
putative	NULL
GPIIb	NULL
8934	NULL
+1	NULL
ATG	NULL
+35	NULL
rd	NULL
~643	NULL
\_	NULL
,	NULL
+33	NULL
Xba	NULL
1	NULL
«	NULL
<	NULL
pBLCAT3	NULL
4.3	NULL
kb	NULL
Expression	NULL
of	NULL
Platelet	NULL
GPIIb	NULL
Gene	NULL
RSV	NULL
IIb	NULL
Hela	NULL
Raji	NULL
HEL	NULL
Hela	NULL
Raji	NULL
HEL	NULL
a	NULL
b	NULL
C	NULL
d	NULL
e	NULL
f	NULL
«	NULL
-	NULL
@	NULL
@	NULL
&	NULL
A	NULL
B	NULL
bald	NULL
oa	NULL
c	NULL
A	NULL
A	NULL
&	NULL
A	NULL
M	NULL
+1	NULL
+33	NULL
ad	NULL
[	NULL
Cat	NULL
3	NULL
203	NULL
**	NULL
3	NULL
-	NULL
2	NULL
-I	NULL
1	NULL
183	NULL
N-	NULL
*	NULL
18	NULL
3	NULL
=l®	NULL
ﬂ	NULL
1+	NULL
3	NULL
4	NULL
203	NULL
C	NULL
D	NULL
-	NULL
rna	NULL
_	NULL
imcat	NULL
plasmid	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
GPIIb	NULL
gene	NULL
in	NULL
HEL	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
corresponding	NULL
to	NULL
the	NULL
genomic	NULL
sequence	NULL
from	NULL
position	NULL
-643	NULL
to	NULL
-33	NULL
was	NULL
generated	NULL
by	NULL
Exolll	NULL
digestion	NULL
of	NULL
a	NULL
Mbol-Mbol	NULL
1080-bp	NULL
fragment	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
was	NULL
analyzed	NULL
in	NULL
a	NULL
CAT	NULL
assay	NULL
after	NULL
transient	NULL
transfection	NULL
of	NULL
different	NULL
cell	NULL
lines	NULL
using	NULL
pBLCAT3	NULL
vector	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
panel	NULL
B	NULL
,	NULL
lanes	NULL
a	NULL
to	NULL
c	NULL
)	NULL
,	NULL
HeLa	NULL
cells	NULL
(	NULL
lane	NULL
a	NULL
)	NULL
,	NULL
Raji	NULL
cells	NULL
(	NULL
lane	NULL
b	NULL
)	NULL
,	NULL
and	NULL
HEL	NULL
cells	NULL
(	NULL
lane	NULL
c	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
pBLRSVCAT3	NULL
vector	NULL
.	NULL

As	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
the	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
plasmid	NULL
pRSVL	NULL
.	NULL

The	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
volume	NULL
of	NULL
protein	NULL
extracts	NULL
corresponding	NULL
to	NULL
5	NULL
arbitrary	NULL
units	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

In	NULL
lanes	NULL
d-f	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
IIbpBLCAT3	NULL
and	NULL
PRSVL	NULL
,	NULL
and	NULL
the	NULL
volume	NULL
of	NULL
protein	NULL
extract	NULL
that	NULL
was	NULL
used	NULL
for	NULL
the	NULL
CAT	NULL
assay	NULL
corresponded	NULL
to	NULL
20	NULL
units	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

When	NULL
the	NULL
CAT	NULL
activity	NULL
obtained	NULL
after	NULL
transfection	NULL
with	NULL
the	NULL
RSV	NULL
promoter	NULL
in	NULL
Raji	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
HEL	NULL
cells	NULL
was	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
,	NULL
the	NULL
average	NULL
CAT	NULL
activity	NULL
with	NULL
GPIIb	NULL
promoter	NULL
was	NULL
0	NULL
%	NULL
in	NULL
Raji	NULL
cells	NULL
(	NULL
not	NULL
detectable	NULL
)	NULL
,	NULL
1.7	NULL
+	NULL
1.5	NULL
%	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
15	NULL
+	NULL
2	NULL
%	NULL
in	NULL
HEL	NULL
cells	NULL
.	NULL

To	NULL
verify	NULL
if	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
fusion	NULL
GPIIb	NULL
CAT	NULL
transcript	NULL
was	NULL
correctly	NULL
initiated	NULL
,	NULL
the	NULL
transfected	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
reverse	NULL
transcribed	NULL
with	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
using	NULL
oligo	NULL
1	NULL
as	NULL
primer	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
reaction	NULL
was	NULL
performed	NULL
on	NULL
the	NULL
cDNA	NULL
with	NULL
oligo	NULL
2	NULL
or	NULL
oligo	NULL
3	NULL
as	NULL
second	NULL
primer	NULL
(	NULL
panel	NULL
D	NULL
,	NULL
RNA	NULL
,	NULL
1	NULL
+	NULL
2	NULL
and	NULL
1	NULL
+	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

A	NULL
control	NULL
experiment	NULL
was	NULL
done	NULL
on	NULL
IIbCAT	NULL
plasmid	NULL
with	NULL
the	NULL
same	NULL
oligonucleotides	NULL
(	NULL
panel	NULL
D	NULL
,	NULL
IIbCAT	NULL
plasmid	NULL
,	NULL
1	NULL
+	NULL
2	NULL
and	NULL
1	NULL
+	NULL
3	NULL
)	NULL
.	NULL

regulatory	NULL
signals	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
with	NULL
that	NULL
obtained	NULL
with	NULL
cells	NULL
transfected	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
plasmid	NULL
pRSVCAT	NULL
,	NULL
containing	NULL
the	NULL
highly	NULL
active	NULL
and	NULL
ubiquitous	NULL
RSV	NULL
promoter	NULL
.	NULL

The	NULL
vector	NULL
pBLCAT3	NULL
,	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
any	NULL
eukaryotic	NULL
promoter	NULL
region	NULL
,	NULL
was	NULL
used	NULL
in	NULL
control	NULL
experiments	NULL
.	NULL

The	NULL
different	NULL
constructs	NULL
were	NULL
cotransfected	NULL
in	NULL
HEL	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
,	NULL
with	NULL
the	NULL
plasmid	NULL
pRSVL	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
reference	NULL
to	NULL
evaluate	NULL
the	NULL
transfection	NULL
efficiency	NULL
.	NULL

As	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
the	NULL
RSV	NULL
promoter	NULL
was	NULL
efficient	NULL
in	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
vector	NULL
pBLIIbCAT3	NULL
induced	NULL
an	NULL
efficient	NULL
expression	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activity	NULL
only	NULL
in	NULL
HEL	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
676-bp	NULL
fragment	NULL
was	NULL
inserted	NULL
in	NULL
the	NULL
opposite	NULL
direction	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
in	NULL
HEL	NULL
cells	NULL
was	NULL
abolished	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
IIb	NULL
promoter	NULL
,	NULL
the	NULL
percentages	NULL
of	NULL
chloramphenicol	NULL
conversion	NULL
induced	NULL
by	NULL
the	NULL
IIb	NULL
promoter	NULL
and	NULL
the	NULL
RSV	NULL
promoter	NULL
were	NULL
compared	NULL
in	NULL
a	NULL
homogeneous	NULL
system	NULL
,	NULL
using	NULL
the	NULL
same	NULL
transfection	NULL
technique	NULL
and	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
were	NULL
normalized	NULL
with	NULL
an	NULL
internal	NULL
control	NULL
using	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

When	NULL
the	NULL
value	NULL
obtained	NULL
from	NULL
the	NULL
RSV	NULL
promoter	NULL
was	NULL
taken	NULL
as	NULL
the	NULL
100	NULL
%	NULL
value	NULL
,	NULL
an	NULL
average	NULL
of	NULL
15	NULL
+	NULL
2	NULL
%	NULL
conversion	NULL
was	NULL
obtained	NULL
for	NULL
the	NULL
IIb	NULL
promoter	NULL
in	NULL
HEL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

From	NULL
these	NULL
results	NULL
,	NULL
we	NULL
con	NULL
-853	NULL
-598	NULL
=	NULL
%	NULL
.	NULL

+616	NULL
Enel	NULL
Haelll	NULL
EcoRI	NULL
£______J	NULL
_	NULL
zzz	NULL
-S	NULL
-	NULL
BO	NULL
]	NULL
f	NULL
,	NULL
1	NULL
+104	NULL
fl	NULL
\\\	NULL
f	NULL
,	NULL
\	NULL
.	NULL

4	NULL
\\	NULL
‘	NULL
4	NULL
_	NULL
WML	NULL
___	NULL
sommes	NULL
/	NULL
-428	NULL
~15200-3	NULL
+35	NULL
/-548	NULL
v	NULL
-357	NULL
iI	NULL
sussbiious	NULL
/	NULL
v	NULL
-154	NULL
0-6	NULL
[	NULL
emmm	NULL
-598	NULL
-488	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Different	NULL
DNA	NULL
fragments	NULL
from	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
GPIIb	NULL
gene	NULL
were	NULL
produced	NULL
with	NULL
the	NULL
PCR	NULL
pro-cedure	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
each	NULL
was	NULL
verified	NULL
prior	NULL
to	NULL
5¢	NULL
end-labeled	NULL
and	NULL
DNase	NULL
I	NULL
protection	NULL
assays	NULL
.	NULL

cluded	NULL
that	NULL
the	NULL
676-bp	NULL
fragment	NULL
contains	NULL
sequences	NULL
that	NULL
are	NULL
sufficient	NULL
to	NULL
confer	NULL
transcription	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
when	NULL
tested	NULL
in	NULL
transient	NULL
assays	NULL
.	NULL

The	NULL
Promoter	NULL
Region	NULL
of	NULL
the	NULL
GPIIb	NULL
Gene	NULL
Contains	NULL
Multiple	NULL
Binding	NULL
Sites	NULL
for	NULL
Nuclear	NULL
Factors-To	NULL
map	NULL
the	NULL
binding	NULL
sites	NULL
of	NULL
nuclear	NULL
factors	NULL
on	NULL
the	NULL
GPIIb	NULL
gene	NULL
5'-flanking	NULL
sequence	NULL
,	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
+93	NULL
and	NULL
-598	NULL
was	NULL
further	NULL
analyzed	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Different	NULL
DNA	NULL
fragments	NULL
corresponding	NULL
to	NULL
this	NULL
fragment	NULL
were	NULL
produced	NULL
with	NULL
the	NULL
PCR	NULL
technique	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
each	NULL
of	NULL
which	NULL
was	NULL
5	NULL
end-labeled	NULL
for	NULL
Expression	NULL
of	NULL
Platelet	NULL
GPIIb	NULL
Gene	NULL
protection	NULL
assays	NULL
and	NULL
cut	NULL
with	NULL
selected	NULL
restriction	NULL
enzymes	NULL
to	NULL
generate	NULL
one	NULL
strand-labeled	NULL
fragment	NULL
.	NULL

The	NULL
DNA	NULL
segment	NULL
was	NULL
analyzed	NULL
for	NULL
protection	NULL
at	NULL
both	NULL
strands	NULL
.	NULL

The	NULL
protected	NULL
areas	NULL
illustrated	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
were	NULL
the	NULL
same	NULL
on	NULL
both	NULL
strands	NULL
.	NULL

Fragment	NULL
I	NULL
,	NULL
which	NULL
contains	NULL
95	NULL
bp	NULL
downstream	NULL
from	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
and	NULL
includes	NULL
part	NULL
of	NULL
exon	NULL
I	NULL
,	NULL
did	NULL
not	NULL
show	NULL
any	NULL
protected	NULL
area	NULL
and	NULL
was	NULL
not	NULL
further	NULL
analyzed	NULL
.	NULL

Fragment	NULL
II	NULL
,	NULL
spanning	NULL
the	NULL
area	NULL
between	NULL
nucleotides	NULL
-6	NULL
and	NULL
-154	NULL
,	NULL
showed	NULL
one	NULL
protected	NULL
region	NULL
,	NULL
designated	NULL
domain	NULL
A	NULL
,	NULL
centered	NULL
at	NULL
-54	NULL
.	NULL

This	NULL
domain	NULL
contains	NULL
a	NULL
20-bp	NULL
core	NULL
sequence	NULL
that	NULL
was	NULL
specifically	NULL
protected	NULL
by	NULL
nuclear	NULL
factors	NULL
prepared	NULL
from	NULL
HEL	NULL
cells	NULL
.	NULL

Fragment	NULL
III	NULL
,	NULL
containing	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
-152	NULL
and	NULL
-428	NULL
,	NULL
showed	NULL
two	NULL
different	NULL
domains	NULL
protected	NULL
by	NULL
both	NULL
HEL	NULL
and	NULL
HeLa	NULL
factors	NULL
.	NULL

One	NULL
footprint	NULL
,	NULL
centered	NULL
at	NULL
-230	NULL
(	NULL
domain	NULL
B	NULL
)	NULL
,	NULL
corresponds	NULL
to	NULL
a	NULL
23-bp	NULL
core	NULL
sequence	NULL
.	NULL

The	NULL
other	NULL
footprint	NULL
,	NULL
centered	NULL
at	NULL
-350	NULL
(	NULL
domain	NULL
C	NULL
)	NULL
,	NULL
corresponds	NULL
to	NULL
a	NULL
24-bp	NULL
protected	NULL
area	NULL
.	NULL

With	NULL
fragment	NULL
IV	NULL
,	NULL
spanning	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
-357	NULL
and	NULL
-548	NULL
,	NULL
two	NULL
footprinted	NULL
areas	NULL
were	NULL
visible	NULL
.	NULL

These	NULL
two	NULL
domains	NULL
,	NULL
D	NULL
(	NULL
19	NULL
bp	NULL
)	NULL
and	NULL
E	NULL
(	NULL
22	NULL
bp	NULL
)	NULL
,	NULL
were	NULL
specifically	NULL
protected	NULL
from	NULL
nucleolytic	NULL
attack	NULL
by	NULL
factors	NULL
from	NULL
HEL	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
fragment	NULL
V	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
sequence	NULL
between	NULL
nucleotides	NULL
-488	NULL
and	NULL
-598	NULL
and	NULL
overlaps	NULL
fragment	NULL
IV	NULL
,	NULL
showed	NULL
two	NULL
footprinted	NULL
areas	NULL
.	NULL

One	NULL
of	NULL
these	NULL
two	NULL
footprints	NULL
corresponds	NULL
to	NULL
domain	NULL
E	NULL
,	NULL
which	NULL
again	NULL
was	NULL
specifically	NULL
protected	NULL
by	NULL
HEL	NULL
factors	NULL
;	NULL
the	NULL
other	NULL
region	NULL
,	NULL
domain	NULL
F	NULL
(	NULL
32	NULL
bp	NULL
)	NULL
,	NULL
was	NULL
protected	NULL
by	NULL
both	NULL
HEL	NULL
and	NULL
HeLa	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
corresponding	NULL
to	NULL
the	NULL
protected	NULL
areas	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
these	NULL
sequences	NULL
with	NULL
other	NULL
known	NULL
binding	NULL
sites	NULL
revealed	NULL
a	NULL
number	NULL
of	NULL
interesting	NULL
features	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
5'-GATAAGAA-3	NULL
'	NULL
motif	NULL
within	NULL
the	NULL
protected	NULL
sequence	NULL
of	NULL
domain	NULL
A	NULL
suggests	NULL
that	NULL
this	NULL
domain	NULL
may	NULL
have	NULL
a	NULL
function	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
a	NULL
GATA	NULL
box	NULL
present	NULL
in	NULL
regulatory	NULL
regions	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
that	NULL
interacts	NULL
-154	NULL
-6	NULL
-428	NULL
-152	NULL
C	NULL
HEL	NULL
Hela	NULL
C	NULL
HEL	NULL
Hela	NULL
147	NULL
@	NULL
19¢	NULL
ai	NULL
E	NULL
<	NULL
3¥56	NULL
a	NULL
180	NULL
B	NULL
``	NULL
=	NULL
L	NULL
a	NULL
|-	NULL
#	NULL
~243	NULL
``	NULL
*	NULL
we	NULL
#	NULL
(	NULL
-	NULL
:	NULL
160	NULL
z	NULL
a	NULL
[	NULL
A	NULL
147	NULL
®	NULL
so	NULL
&	NULL
s	NULL
6s	NULL
e	NULL
3	NULL
aw	NULL
a+	NULL
1	NULL
*	NULL
§	NULL
Z	NULL
-	NULL
1	NULL
:	NULL
@	NULL
B	NULL
67	NULL
&	NULL
y	NULL
we	NULL
*-m	NULL
®	NULL
110	NULL
Q	NULL
,	NULL
&	NULL
t	NULL
f	NULL
c	NULL
.	NULL

¢	NULL
-338	NULL
¥	NULL
t	NULL
,	NULL
&	NULL
90	NULL
.	NULL

f	NULL
*	NULL
>	NULL
$	NULL
a	NULL
&	NULL
I	NULL
c	NULL
#	NULL
*	NULL
76	NULL
26	NULL
@	NULL
Q	NULL
,	NULL
362	NULL
1	NULL
&	NULL
€	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
GPIIb	NULL
promoter	NULL
region	NULL
.	NULL

5	NULL
'	NULL
end-labeled	NULL
PCR	NULL
fragments	NULL
,	NULL
including	NULL
the	NULL
sequences	NULL
from	NULL
nucleotide	NULL
-6	NULL
to	NULL
-154	NULL
and	NULL
from	NULL
-152	NULL
to	NULL
-428	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
)	NULL
-poly	NULL
(	NULL
dC	NULL
)	NULL
and	NULL
digested	NULL
with	NULL
4	NULL
units	NULL
of	NULL
DNase	NULL
I	NULL
.	NULL

Lane	NULL
C	NULL
corresponds	NULL
to	NULL
the	NULL
digestion	NULL
of	NULL
the	NULL
fragment	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Following	NULL
digestion	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
run	NULL
on	NULL
8	NULL
%	NULL
acrylamide-sequencing	NULL
gels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
8	NULL
M	NULL
urea	NULL
.	NULL

8935	NULL
*S48	NULL
«	NULL
8357	NULL
-	NULL
»	NULL
-598	NULL
-488	NULL
c	NULL
HEL	NULL
Hela	NULL
C	NULL
HEL	NULL
Hela	NULL
123	NULL
=	NULL
»	NULL
.	NULL

110	NULL
*	NULL
.	NULL
'	NULL

am	NULL
-456	NULL
so	NULL
t	NULL
t	NULL
90	NULL
Q	NULL
‘	NULL
I	NULL
[	NULL
5	NULL
#	NULL
.	NULL

*	NULL
®	NULL
4	NULL
L	NULL
f	NULL
-502	NULL
16	NULL
4m	NULL
475	NULL
16	NULL
&	NULL
©	NULL
R	NULL
-524	NULL
``	NULL
f	NULL
67	NULL
®	NULL
i	NULL
-530	NULL
«	NULL
g	NULL
'	NULL
H-soz	NULL
g	NULL
i	NULL
F	NULL
«	NULL
«	NULL
we	NULL
A	NULL
-	NULL
%	NULL
F	NULL
l	NULL
4	NULL
%	NULL
|	NULL
:	NULL
C	NULL
&	NULL
:	NULL
$	NULL
-	NULL
La	NULL
:	NULL
&	NULL
e	NULL
«	NULL
.	NULL

%	NULL
-562	NULL
«	NULL
d	NULL
k	NULL
*	NULL
``	NULL
#	NULL
:	NULL
26	NULL
L	NULL
I	NULL
*	NULL
y	NULL
~S24	NULL
34	NULL
=	NULL
g	NULL
s	NULL
+	NULL
&	NULL
4	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
GPIIb	NULL
promoter	NULL
region	NULL
.	NULL

Two	NULL
other	NULL
PCR	NULL
fragments	NULL
containing	NULL
the	NULL
sequences	NULL
from	NULL
nucleotide	NULL
-357	NULL
to	NULL
-548	NULL
and	NULL
from	NULL
-488	NULL
to	NULL
-598	NULL
were	NULL
5	NULL
end-labeled	NULL
and	NULL
analyzed	NULL
in	NULL
protection	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
under	NULL
the	NULL
conditions	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Lane	NULL
C	NULL
represents	NULL
the	NULL
digestion	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

TABLE	NULL
I	NULL
Homologies	NULL
of	NULL
the	NULL
protected	NULL
region	NULL
of	NULL
the	NULL
GPIIb	NULL
promoter	NULL
with	NULL
other	NULL
promoter	NULL
sequences	NULL
The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
GPIb	NULL
(	NULL
hGPIb	NULL
)	NULL
gene	NULL
were	NULL
obtained	NULL
from	NULL
Wenger	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
;	NULL
sequences	NULL
of	NULL
the	NULL
rat	NULL
PF4	NULL
(	NULL
rPF4	NULL
)	NULL
gene	NULL
are	NULL
from	NULL
Doi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
mouse	NULL
-globin	NULL
(	NULL
m	NULL
a-globin	NULL
)	NULL
NF-E1	NULL
site	NULL
and	NULL
to	NULL
the	NULL
human	NULL
a-globin	NULL
(	NULL
h	NULL
a-globin	NULL
)	NULL
CAAT	NULL
box	NULL
are	NULL
from	NULL
Plumb	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
and	NULL
Chodosh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
(	NULL
hPBGD	NULL
)	NULL
is	NULL
from	NULL
Mignotte	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
.	NULL

Gene	NULL
Sequence	NULL
Domain	NULL
A	NULL
TT	NULL
GATAAGAA	NULL
hGPIb	NULL
GC	NULL
GATAAGGG	NULL
rPF4	NULL
AA	NULL
GATAAAAC	NULL
m	NULL
a-globin	NULL
CT	NULL
GATAAGGA	NULL
hPBGD	NULL
GA	NULL
GATAAGGC	NULL
Domain	NULL
B	NULL
AG	NULL
AACCAATAG	NULL
h	NULL
-globin	NULL
CC	NULL
AGCCAATGA	NULL
Domain	NULL
C	NULL
AGGCTAGAGTAGA	NULL
Domain	NULL
D	NULL
TCAGGTTTTATCG	NULL
Domain	NULL
E	NULL
GGTCCTAGAAGGAG	NULL
hGPIb	NULL
CACCCTAGAAGACG	NULL
Domain	NULL
F	NULL
AATATGGCTGTTG	NULL
rPF4	NULL
ATCTTGGCTGGCC	NULL
with	NULL
the	NULL
nuclear	NULL
factor	NULL
E1	NULL
(	NULL
44-46	NULL
)	NULL
.	NULL

This	NULL
motif	NULL
is	NULL
also	NULL
present	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
GPIb	NULL
and	NULL
the	NULL
PF4	NULL
genes	NULL
,	NULL
two	NULL
other	NULL
megakaryocyte-specific	NULL
genes	NULL
that	NULL
have	NULL
recently	NULL
been	NULL
cloned	NULL
(	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Domain	NULL
B	NULL
contains	NULL
the	NULL
motif	NULL
5'-AAC-CAAT-3	NULL
'	NULL
,	NULL
which	NULL
resembles	NULL
the	NULL
consensus	NULL
CAAT	NULL
box	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Domain	NULL
C	NULL
and	NULL
domain	NULL
D	NULL
do	NULL
not	NULL
contain	NULL
homology	NULL
with	NULL
known	NULL
binding	NULL
sites	NULL
,	NULL
whereas	NULL
domain	NULL
E	NULL
contains	NULL
an	NULL
octamer	NULL
,	NULL
5'-CCTAGAA-3	NULL
'	NULL
,	NULL
also	NULL
present	NULL
within	NULL
the	NULL
5	NULL
sequence	NULL
of	NULL
the	NULL
GP	NULL
Ib	NULL
gene	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
domain	NULL
F	NULL
contains	NULL
a	NULL
5	NULL
(	NULL
-GGCCGCCC-	NULL
8936	NULL
3	NULL
'	NULL
sequence	NULL
which	NULL
resembles	NULL
an	NULL
Spl-binding	NULL
site	NULL
associated	NULL
with	NULL
a	NULL
motif	NULL
also	NULL
present	NULL
in	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
PF4	NULL
gene	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
from	NULL
these	NULL
results	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
the	NULL
598-bp	NULL
fragment	NULL
contains	NULL
multiple	NULL
protected	NULL
sites	NULL
with	NULL
a	NULL
potential	NULL
binding	NULL
activity	NULL
for	NULL
ubiquitous	NULL
and	NULL
tissue-specific	NULL
nuclear	NULL
proteins	NULL
.	NULL

To	NULL
verify	NULL
which	NULL
individual	NULL
protein	NULL
might	NULL
interact	NULL
with	NULL
the	NULL
different	NULL
protected	NULL
domains	NULL
,	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
protected	NULL
sequences	NULL
were	NULL
analyzed	NULL
in	NULL
direct	NULL
binding	NULL
experiments	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Domain	NULL
A	NULL
Contains	NULL
a	NULL
Binding	NULL
Site	NULL
for	NULL
a	NULL
NF-E1-like	NULL
Pro-tein-When	NULL
an	NULL
oligomer	NULL
,	NULL
containing	NULL
the	NULL
protected	NULL
sequence	NULL
of	NULL
the	NULL
region	NULL
A	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
vast	NULL
excess	NULL
of	NULL
the	NULL
nonspecific	NULL
competitor	NULL
poly	NULL
(	NULL
dI	NULL
)	NULL
-poly	NULL
(	NULL
dC	NULL
)	NULL
,	NULL
one	NULL
major	NULL
DNA-protein	NULL
complex	NULL
was	NULL
formed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
nonlabeled	NULL
oligomer	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
,	NULL
whereas	NULL
a	NULL
nonrelated	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
HNF1-binding	NULL
site	NULL
did	NULL
not	NULL
compete	NULL
with	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
domain	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
oligo	NULL
A	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
HeLa	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
several	NULL
retarded	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

But	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
nonlabeled	NULL
oligomer	NULL
containing	NULL
the	NULL
HNF1-binding	NULL
site	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
were	NULL
due	NULL
to	NULL
nonspecific	NULL
interactions	NULL
.	NULL

Since	NULL
domain	NULL
A	NULL
contains	NULL
a	NULL
GATAA	NULL
motif	NULL
that	NULL
functions	NULL
as	NULL
an	NULL
NF-E1-binding	NULL
site	NULL
,	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
GATA	NULL
box	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
«	NULL
-globin	NULL
gene	NULL
was	NULL
synthesized	NULL
and	NULL
used	NULL
as	NULL
a	NULL
competitor	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
this	NULL
NF-E1	NULL
oligomer	NULL
completely	NULL
abolished	NULL
the	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
oligo	NULL
A	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
domain	NULL
A	NULL
may	NULL
potentially	NULL
interact	NULL
with	NULL
an	NULL
NF-E1-like	NULL
protein	NULL
present	NULL
in	NULL
HEL	NULL
cells	NULL
.	NULL

Domain	NULL
B	NULL
Contains	NULL
a	NULL
CAAT-binding	NULL
Site-From	NULL
the	NULL
protected	NULL
sequence	NULL
of	NULL
footprint	NULL
B	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
CAAT	NULL
element	NULL
was	NULL
suggested	NULL
.	NULL

To	NULL
verify	NULL
this	NULL
possibility	NULL
,	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
this	NULL
sequence	NULL
was	NULL
synthesized	NULL
and	NULL
its	NULL
binding	NULL
activity	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
an	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
CAAT	NULL
-binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
«	NULL
-globin	NULL
gene	NULL
.	NULL

Both	NULL
oligos	NULL
gave	NULL
rise	NULL
to	NULL
one	NULL
DNA-protein	NULL
com	NULL
HEL	NULL
Hela	NULL
1.2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
U	NULL
U	NULL
``	NULL
it	NULL
_	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Proteins	NULL
binding	NULL
to	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
footprint	NULL
A	NULL
.	NULL

A	NULL
synthetic	NULL
oligonucleotide	NULL
carrying	NULL
the	NULL
protected	NULL
DNA	NULL
sequence	NULL
of	NULL
domain	NULL
A	NULL
was	NULL
end-labeled	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
proteins	NULL
of	NULL
HEL	NULL
cells	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
with	NULL
0.2-0.5	NULL
ug	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
)	NULL
-	NULL
poly	NULL
(	NULL
dC	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng	NULL
of	NULL
cold	NULL
oligo	NULL
H	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng	NULL
of	NULL
an	NULL
oligo	NULL
carrying	NULL
the	NULL
HNF1-binding	NULL
site	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
of	NULL
an	NULL
oligo	NULL
corresponding	NULL
to	NULL
the	NULL
NFE2-binding	NULL
site	NULL
from	NULL
mouse	NULL
«	NULL
-globin	NULL
promoter	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
40	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Expression	NULL
of	NULL
Platelet	NULL
GPIIb	NULL
Gene	NULL
plex	NULL
of	NULL
identical	NULL
electrophoretic	NULL
mobility	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
interacting	NULL
with	NULL
the	NULL
globin	NULL
CAAT	NULL
element	NULL
was	NULL
present	NULL
in	NULL
both	NULL
cells	NULL
and	NULL
was	NULL
competed	NULL
with	NULL
a	NULL
similar	NULL
efficiency	NULL
by	NULL
the	NULL
nonlabeled	NULL
GP	NULL
IIb	NULL
and	NULL
globin	NULL
CAAT	NULL
oligomers	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
oligo	NULL
carrying	NULL
the	NULL
nonrelated	NULL
HNF1-binding	NULL
site	NULL
had	NULL
no	NULL
effect	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

With	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
cells	NULL
,	NULL
competition	NULL
with	NULL
the	NULL
-globin	NULL
CAAT	NULL
or	NULL
IIb	NULL
CAAT	NULL
sequences	NULL
were	NULL
similar	NULL
.	NULL

Competition	NULL
of	NULL
the	NULL
-globin	NULL
CAAT	NULL
oligomer	NULL
with	NULL
itself	NULL
was	NULL
slightly	NULL
less	NULL
efficient	NULL
than	NULL
with	NULL
IIb	NULL
CAAT	NULL
oligomer	NULL
when	NULL
nuclear	NULL
extract	NULL
from	NULL
HeLa	NULL
cells	NULL
were	NULL
used	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
discrepancy	NULL
is	NULL
unknown	NULL
.	NULL

The	NULL
two	NULL
oligomers	NULL
do	NULL
not	NULL
have	NULL
exactly	NULL
the	NULL
same	NULL
core	NULL
sequence	NULL
,	NULL
however	NULL
.	NULL

Though	NULL
the	NULL
CAAT-binding	NULL
proteins	NULL
from	NULL
HeLa	NULL
and	NULL
HEL	NULL
cells	NULL
exhibit	NULL
the	NULL
same	NULL
molecular	NULL
weight	NULL
,	NULL
they	NULL
may	NULL
differ	NULL
slightly	NULL
in	NULL
their	NULL
affinity	NULL
for	NULL
the	NULL
two	NULL
sequences	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
family	NULL
of	NULL
CAAT	NULL
-binding	NULL
proteins	NULL
present	NULL
in	NULL
different	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Proteins	NULL
Binding	NULL
to	NULL
Domains	NULL
C	NULL
and	NULL
F-The	NULL
footprint	NULL
C	NULL
was	NULL
observed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

A	NULL
30-bp	NULL
fragment	NULL
carrying	NULL
the	NULL
protected	NULL
sequence	NULL
was	NULL
synthesized	NULL
and	NULL
analyzed	NULL
for	NULL
protein	NULL
binding	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
a	NULL
similar	NULL
retardation	NULL
pattern	NULL
was	NULL
observed	NULL
with	NULL
proteins	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Two	NULL
major	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
formed	NULL
.	NULL

Both	NULL
of	NULL
them	NULL
were	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
HEL	NULL
Hela	NULL
102	NULL
8	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
#	NULL
-	NULL
==	NULL
“	NULL
J	NULL
FiG	NULL
.	NULL

6	NULL
.	NULL

Interaction	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
with	NULL
the	NULL
protected	NULL
domain	NULL
B	NULL
.	NULL

The	NULL
conditions	NULL
for	NULL
the	NULL
binding	NULL
reactions	NULL
and	NULL
the	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
those	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
and	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
the	NULL
oligo	NULL
B	NULL
was	NULL
incubated	NULL
with	NULL
proteins	NULL
from	NULL
HEL	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complex	NULL
formed	NULL
was	NULL
inhibited	NULL
by	NULL
50	NULL
ng	NULL
of	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
carrying	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
CAAT-binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
«	NULL
-globin	NULL
gene	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
the	NULL
oligo	NULL
corresponding	NULL
to	NULL
the	NULL
-globin	NULL
gene	NULL
was	NULL
incubated	NULL
with	NULL
extracts	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
nonlabeled	NULL
oligo	NULL
B	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
«	NULL
-globin	NULL
CAAT	NULL
site	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
HNF1-binding	NULL
sites	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

A	NULL
B	NULL
EL	NULL
Hela	NULL
HEL	NULL
Hela	NULL
1	NULL
2	NULL
3	NULL
1	NULL
208	NULL
102	NULL
3	NULL
1	NULL
203	NULL
Nun	NULL
...	NULL
-	NULL
liken	NULL
_	NULL
hi	NULL
aa	NULL
wine	NULL
.	NULL

Mh	NULL
as	NULL
dci	NULL
FiG	NULL
.	NULL

7	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
protected	NULL
domains	NULL
C	NULL
and	NULL
F.	NULL
Panel	NULL
A	NULL
,	NULL
end-labeled	NULL
oligo	NULL
C	NULL
was	NULL
incubated	NULL
with	NULL
extracts	NULL
from	NULL
HEL	NULL
or	NULL
HeLa	NULL
cells	NULL
and	NULL
analyzed	NULL
using	NULL
the	NULL
procedure	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
nonlabeled	NULL
oligo	NULL
C	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
HNF1-binding	NULL
site	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
end-labeled	NULL
oligo	NULL
F	NULL
was	NULL
incubated	NULL
with	NULL
proteins	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
and	NULL
analyzed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
large	NULL
excess	NULL
of	NULL
cold	NULL
oligo	NULL
F	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
HNF1-binding	NULL
site	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Platelet	NULL
GPIIb	NULL
Gene	NULL
of	NULL
nonlabeled	NULL
oligo	NULL
C	NULL
,	NULL
but	NULL
the	NULL
oligo	NULL
carrying	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
HNF1-binding	NULL
site	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
high	NULL
molecular	NULL
weight	NULL
complex	NULL
only	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
domain	NULL
corresponding	NULL
to	NULL
footprint	NULL
C	NULL
can	NULL
form	NULL
one	NULL
specific	NULL
complex	NULL
with	NULL
the	NULL
ubiquitous	NULL
protein	NULL
present	NULL
in	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
synthetic	NULL
oligonucleotides	NULL
carrying	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
protected	NULL
domain	NULL
F	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Several	NULL
retarded	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
proteins	NULL
from	NULL
HEL	NULL
and	NULL
HeLa	NULL
cells	NULL
with	NULL
oligo	NULL
F.	NULL
In	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
large	NULL
excess	NULL
of	NULL
the	NULL
nonrelated	NULL
HNF1-binding	NULL
site	NULL
,	NULL
however	NULL
,	NULL
only	NULL
one	NULL
complex	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Domains	NULL
D	NULL
and	NULL
E	NULL
Interact	NULL
with	NULL
Megakaryocyte-specific	NULL
Fac-tors-The	NULL
sequences	NULL
corresponding	NULL
to	NULL
domains	NULL
D	NULL
and	NULL
E	NULL
were	NULL
specifically	NULL
protected	NULL
when	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
HEL	NULL
cells	NULL
were	NULL
used	NULL
,	NULL
suggesting	NULL
the	NULL
formation	NULL
of	NULL
tissue-specific	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
observation	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
protected	NULL
sequences	NULL
D	NULL
and	NULL
E.	NULL
When	NULL
the	NULL
oligo	NULL
D	NULL
was	NULL
incubated	NULL
with	NULL
HEL	NULL
cell	NULL
factors	NULL
,	NULL
only	NULL
one	NULL
complex	NULL
was	NULL
formed	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Formation	NULL
of	NULL
this	NULL
retarded	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
cold	NULL
oligo	NULL
D	NULL
but	NULL
not	NULL
by	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
HNF1-binding	NULL
site	NULL
.	NULL

A	NULL
similar	NULL
DNA-protein	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
nuclear	NULL
proteins	NULL
prepared	NULL
from	NULL
purified	NULL
megakaryocytes	NULL
with	NULL
the	NULL
same	NULL
inhibition	NULL
pattern	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
oligo	NULL
D	NULL
with	NULL
factors	NULL
from	NULL
nonmegakaryocytic	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
several	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Formation	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
,	NULL
however	NULL
,	NULL
inhibited	NULL
by	NULL
both	NULL
cold	NULL
oligo	NULL
D	NULL
and	NULL
the	NULL
oligo	NULL
carrying	NULL
the	NULL
HNF1-binding	NULL
site	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
complexes	NULL
were	NULL
due	NULL
to	NULL
nonspecific	NULL
interactions	NULL
.	NULL

When	NULL
similar	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
oligo	NULL
E	NULL
,	NULL
two	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
proteins	NULL
from	NULL
HEL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
inhibited	NULL
by	NULL
cold	NULL
oligo	NULL
E	NULL
but	NULL
not	NULL
by	NULL
the	NULL
HNF1-binding	NULL
site	NULL
.	NULL

Since	NULL
the	NULL
sequence	NULL
corresponding	NULL
to	NULL
the	NULL
domain	NULL
E	NULL
contains	NULL
a	NULL
TAGA	NULL
motif	NULL
that	NULL
is	NULL
repeated	NULL
twice	NULL
in	NULL
the	NULL
domain	NULL
C	NULL
,	NULL
competition	NULL
with	NULL
cold	NULL
oligo	NULL
C	NULL
was	NULL
also	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
oligo	NULL
C	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
two	NULL
complexes	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
the	NULL
two	NULL
complexes	NULL
were	NULL
interacting	NULL
specifically	NULL
with	NULL
domain	NULL
E	NULL
and	NULL
that	NULL
the	NULL
TAGA	NULL
motif	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
these	NULL
interactions	NULL
.	NULL

The	NULL
two	NULL
retarded	NULL
bands	NULL
were	NULL
also	NULL
observed	NULL
with	NULL
nuclear	NULL
proteins	NULL
prepared	NULL
from	NULL
purified	NULL
megakaryocytes	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
incubation	NULL
of	NULL
oligo	NULL
E	NULL
with	NULL
factors	NULL
from	NULL
nonmegakaryocytic	NULL
cells	NULL
resulted	NULL
HEL	NULL
MEG	NULL
vos	NULL
?	NULL

Hela	NULL
HL6O	NULL
10	NULL
20	NULL
3	NULL
1	NULL
20	NULL
3	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
&	NULL
1	NULL
“	NULL
?	NULL

!	NULL

Fig	NULL
.	NULL

8	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
synthetic	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
domain	NULL
D.	NULL
End-labeled	NULL
oligo	NULL
D	NULL
was	NULL
incubated	NULL
with	NULL
extracts	NULL
from	NULL
HEL	NULL
,	NULL
megakaryocyte	NULL
(	NULL
MEG	NULL
)	NULL
,	NULL
U937	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
HL60	NULL
and	NULL
analyzed	NULL
in	NULL
a	NULL
band	NULL
shift	NULL
assay	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
nonlabeled	NULL
oligo	NULL
D	NULL
or	NULL
HNF1-binding	NULL
site	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

8937	NULL
HEL	NULL
M	NULL
HL	NULL
U	NULL
-	NULL
Hela	NULL
102	NULL
30	NULL
4	NULL
5	NULL
60	NULL
70	NULL
8	NULL
9	NULL
bub	NULL
-	NULL
bub	NULL
(	NULL
up	NULL
tuh	NULL
pf	NULL
til	NULL
44	NULL
16	NULL
-W	NULL
dW	NULL
.	NULL
``	NULL

Fic	NULL
.	NULL

9	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
synthetic	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
domain	NULL
E.	NULL
End-labeled	NULL
oligo	NULL
E	NULL
was	NULL
incubated	NULL
with	NULL
extracts	NULL
from	NULL
HEL	NULL
,	NULL
megakaryocyte	NULL
(	NULL
M	NULL
)	NULL
,	NULL
HL60	NULL
(	NULL
HL	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
U	NULL
)	NULL
,	NULL
and	NULL
HeLa	NULL
and	NULL
analyzed	NULL
in	NULL
a	NULL
band	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5-8	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
either	NULL
cold	NULL
competitor	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
HNF1-binding	NULL
site	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
or	NULL
cold	NULL
oligo	NULL
C	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

%	NULL
OF	NULL
CAT	NULL
ACTIVITY	NULL
-526	NULL
~501	NULL
477	NULL
455	NULL
i	NULL
bri—	NULL
+33	NULL
E	NULL
b	NULL
lls	NULL
-6as	NULL
l	NULL
I	NULL
lg	NULL
100	NULL
(	NULL
~	NULL
I	NULL
cat	NULL
I	NULL
109	NULL
&	NULL
21	NULL
FiG	NULL
.	NULL

10	NULL
.	NULL

5	NULL
deletion	NULL
analysis	NULL
of	NULL
GPIIb	NULL
promoter	NULL
.	NULL

The	NULL
fragments	NULL
extending	NULL
from	NULL
+33	NULL
to	NULL
-414	NULL
,	NULL
-553	NULL
,	NULL
and	NULL
-643	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
subcloned	NULL
in	NULL
the	NULL
pBLCAT3	NULL
vector	NULL
and	NULL
analyzed	NULL
in	NULL
CAT	NULL
assays	NULL
after	NULL
transient	NULL
transfection	NULL
of	NULL
HEL	NULL
cells	NULL
.	NULL

Protein-binding	NULL
regions	NULL
D	NULL
and	NULL
E	NULL
are	NULL
represented	NULL
by	NULL
solid	NULL
boxes	NULL
.	NULL

The	NULL
arrow	NULL
identifies	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
CAT	NULL
conversion	NULL
corresponding	NULL
to	NULL
each	NULL
fragment	NULL
are	NULL
indicated	NULL
;	NULL
when	NULL
the	NULL
CAT	NULL
activity	NULL
corresponding	NULL
to	NULL
the	NULL
fragment	NULL
extending	NULL
to	NULL
-643	NULL
was	NULL
taken	NULL
as	NULL
100	NULL
%	NULL
,	NULL
an	NULL
average	NULL
of	NULL
109	NULL
+	NULL
21	NULL
and	NULL
32	NULL
+	NULL
9	NULL
%	NULL
of	NULL
CAT	NULL
conversion	NULL
was	NULL
found	NULL
with	NULL
fragments	NULL
extending	NULL
from	NULL
-553	NULL
to	NULL
+33	NULL
and	NULL
from	NULL
-414	NULL
to	NULL
+33	NULL
,	NULL
respectively	NULL
.	NULL

32	NULL
+	NULL
9	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
only	NULL
one	NULL
retarded	NULL
electrophoretic	NULL
band	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
complex	NULL
of	NULL
higher	NULL
molecular	NULL
weight	NULL
.	NULL

A	NULL
2-fold	NULL
increase	NULL
of	NULL
the	NULL
concentration	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
HeLa	NULL
cells	NULL
did	NULL
not	NULL
modify	NULL
this	NULL
pattern	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
this	NULL
retarded	NULL
complex	NULL
of	NULL
high	NULL
molecular	NULL
weight	NULL
was	NULL
similarly	NULL
inhibited	NULL
by	NULL
cold	NULL
oligo	NULL
E	NULL
but	NULL
not	NULL
by	NULL
the	NULL
HNF1-binding	NULL
site	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
the	NULL
protein	NULL
present	NULL
in	NULL
the	NULL
different	NULL
nuclear	NULL
extracts	NULL
was	NULL
interacting	NULL
specifically	NULL
with	NULL
the	NULL
oligo	NULL
E.	NULL
These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
protection	NULL
assays	NULL
and	NULL
demonstrate	NULL
that	NULL
the	NULL
sequences	NULL
corresponding	NULL
to	NULL
domains	NULL
D	NULL
and	NULL
E	NULL
interact	NULL
with	NULL
nuclear	NULL
factors	NULL
that	NULL
are	NULL
present	NULL
only	NULL
in	NULL
megakaryocytes	NULL
or	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

Domains	NULL
D	NULL
and	NULL
E	NULL
Are	NULL
Necessary	NULL
for	NULL
Tissue-specific	NULL
Expres-sion-To	NULL
verify	NULL
if	NULL
the	NULL
area	NULL
containing	NULL
domains	NULL
D	NULL
and	NULL
E	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
megakaryocyte	NULL
factors	NULL
,	NULL
had	NULL
any	NULL
functional	NULL
activity	NULL
,	NULL
an	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Two	NULL
different	NULL
deletion	NULL
mutants	NULL
were	NULL
constructed	NULL
and	NULL
examined	NULL
in	NULL
transient	NULL
CAT	NULL
assays	NULL
using	NULL
the	NULL
pBLCAT3	NULL
vector	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
first	NULL
mutant	NULL
contained	NULL
the	NULL
region	NULL
from	NULL
nucleotide	NULL
+33	NULL
to	NULL
-553	NULL
,	NULL
including	NULL
the	NULL
D-E	NULL
cluster	NULL
.	NULL

The	NULL
second	NULL
deletion	NULL
mutant	NULL
contained	NULL
the	NULL
sequence	NULL
from	NULL
nucleotide	NULL
+33	NULL
to	NULL
-414	NULL
and	NULL
did	NULL
not	NULL
include	NULL
the	NULL
D-E	NULL
cluster	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
cluster	NULL
reduced	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
by	NULL
60	NULL
%	NULL
when	NULL
the	NULL
mutants	NULL
were	NULL
transfected	NULL
in	NULL
HEL	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
D-E	NULL
cluster	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
tissue-specific	NULL
activity	NULL
of	NULL
the	NULL
GP	NULL
IIb	NULL
promoter	NULL
.	NULL

8938	NULL
DISCUSSION	NULL
Tissue-specific	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
ubiquitous	NULL
trans-acting	NULL
factors	NULL
interacting	NULL
with	NULL
cis-acting	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
,	NULL
associated	NULL
or	NULL
not	NULL
with	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
cell-specific	NULL
nuclear	NULL
proteins	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
mechanisms	NULL
by	NULL
which	NULL
these	NULL
cis-acting	NULL
complexes	NULL
regulate	NULL
transcription	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
are	NULL
not	NULL
yet	NULL
understood	NULL
.	NULL

Identification	NULL
of	NULL
these	NULL
factors	NULL
and	NULL
the	NULL
mechanisms	NULL
that	NULL
control	NULL
their	NULL
transcriptional	NULL
activities	NULL
is	NULL
nevertheless	NULL
a	NULL
critical	NULL
step	NULL
toward	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
processes	NULL
that	NULL
regulate	NULL
cell	NULL
differentiation	NULL
.	NULL

A	NULL
number	NULL
of	NULL
hematopoietic	NULL
genes	NULL
,	NULL
including	NULL
erythroid	NULL
and	NULL
granulocytic	NULL
genes	NULL
,	NULL
have	NULL
recently	NULL
been	NULL
examined	NULL
and	NULL
used	NULL
to	NULL
search	NULL
for	NULL
lineage-specific	NULL
trans-acting	NULL
proteins	NULL
within	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
platelet	NULL
GPIIb	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
megakaryocytes	NULL
and	NULL
represents	NULL
a	NULL
specific	NULL
and	NULL
early	NULL
marker	NULL
for	NULL
this	NULL
lineage	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
this	NULL
gene	NULL
contains	NULL
positive	NULL
responsive	NULL
elements	NULL
that	NULL
are	NULL
sufficient	NULL
to	NULL
direct	NULL
a	NULL
high	NULL
level	NULL
of	NULL
specific	NULL
expression	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

This	NULL
information	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
first	NULL
600	NULL
bases	NULL
upstream	NULL
from	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
containing	NULL
this	NULL
region	NULL
was	NULL
able	NULL
to	NULL
direct	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
,	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
.	NULL

Footprinting	NULL
studies	NULL
and	NULL
binding	NULL
analysis	NULL
of	NULL
this	NULL
600-bp	NULL
domain	NULL
have	NULL
shown	NULL
that	NULL
it	NULL
contains	NULL
two	NULL
separate	NULL
areas	NULL
that	NULL
display	NULL
significant	NULL
interactions	NULL
with	NULL
nuclear	NULL
proteins	NULL
.	NULL

The	NULL
domain	NULL
from	NULL
nucleotides	NULL
-1	NULL
to	NULL
-250	NULL
contains	NULL
a	NULL
CAAT	NULL
motif	NULL
located	NULL
at	NULL
position	NULL
-233	NULL
.	NULL

This	NULL
motif	NULL
matches	NULL
in	NULL
DNA	NULL
sequence	NULL
5-AACCAAT-3	NULL
'	NULL
with	NULL
CAAT	NULL
sites	NULL
from	NULL
many	NULL
eukar-yote	NULL
promoters	NULL
.	NULL

The	NULL
region	NULL
is	NULL
protected	NULL
by	NULL
nuclear	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
protected	NULL
sequence	NULL
forms	NULL
a	NULL
DNA-protein	NULL
complex	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
a	NULL
consensus	NULL
CAAT	NULL
-binding	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
«	NULL
-globin	NULL
gene	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
GP	NULL
IIb	NULL
CAAT	NULL
sequence	NULL
competes	NULL
with	NULL
the	NULL
«	NULL
-globin	NULL
CAAT	NULL
-binding	NULL
site	NULL
and	NULL
is	NULL
located	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
pointing	NULL
toward	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
in	NULL
a	NULL
usual	NULL
orientation	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
ample	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
this	NULL
protected	NULL
sequence	NULL
contains	NULL
the	NULL
CAAT-binding	NULL
site	NULL
of	NULL
the	NULL
GP	NULL
IIb	NULL
promoter	NULL
.	NULL

The	NULL
location	NULL
of	NULL
this	NULL
motif	NULL
at	NULL
position	NULL
-233	NULL
is	NULL
,	NULL
however	NULL
,	NULL
unusual	NULL
.	NULL

Additional	NULL
functional	NULL
assays	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
establish	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
site	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
two	NULL
inverted	NULL
repeats	NULL
in	NULL
this	NULL
area	NULL
may	NULL
,	NULL
however	NULL
,	NULL
induce	NULL
a	NULL
specific	NULL
looping	NULL
of	NULL
the	NULL
DNA	NULL
structure	NULL
,	NULL
which	NULL
would	NULL
bring	NULL
the	NULL
CAAT-binding	NULL
site	NULL
closer	NULL
to	NULL
the	NULL
initiation	NULL
start	NULL
site	NULL
.	NULL

Located	NULL
at	NULL
position	NULL
-54	NULL
,	NULL
the	NULL
GP	NULL
IIb	NULL
promoter	NULL
contains	NULL
a	NULL
5	NULL
GATAAG-3	NULL
'	NULL
motif	NULL
.	NULL

This	NULL
sequence	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
erythroid	NULL
factor	NULL
NF-E1	NULL
(	NULL
85	NULL
,	NULL
44-46	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
GP	NULL
IIb	NULL
gene	NULL
,	NULL
two	NULL
other	NULL
megakaryocyte-specific	NULL
genes	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
genes	NULL
encoding	NULL
GP	NULL
Ib	NULL
and	NULL
PF4	NULL
(	NULL
47-48	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
contain	NULL
such	NULL
a	NULL
GATA	NULL
box	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
confirm	NULL
that	NULL
this	NULL
site	NULL
may	NULL
function	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
NF-E1-trans-acting	NULL
factor	NULL
or	NULL
for	NULL
a	NULL
protein	NULL
of	NULL
the	NULL
same	NULL
family	NULL
.	NULL

Using	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
in	NULL
a	NULL
separate	NULL
study	NULL
(	NULL
50	NULL
)	NULL
that	NULL
this	NULL
site	NULL
is	NULL
functional	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observations	NULL
from	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
51	NULL
)	NULL
who	NULL
have	NULL
recently	NULL
cloned	NULL
NF-E1	NULL
and	NULL
shown	NULL
that	NULL
this	NULL
factor	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
megakaryocytes	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
megakaryocyte-specific	NULL
promoters	NULL
may	NULL
share	NULL
common	NULL
regulatory	NULL
elements	NULL
with	NULL
erythroid	NULL
genes	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
this	NULL
site	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
GPIIb	NULL
gene	NULL
is	NULL
,	NULL
however	NULL
,	NULL
not	NULL
sufficient	NULL
to	NULL
direct	NULL
an	NULL
efficient	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
5	NULL
region	NULL
contains	NULL
a	NULL
second	NULL
domain	NULL
with	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
proteins	NULL
,	NULL
located	NULL
between	NULL
nucleotides	NULL
-330	NULL
and	NULL
-550	NULL
,	NULL
Two	NULL
binding	NULL
sites	NULL
centered	NULL
at	NULL
positions	NULL
-345	NULL
and	NULL
-540	NULL
,	NULL
Expression	NULL
of	NULL
Platelet	NULL
GPIIb	NULL
Gene	NULL
domain	NULL
C	NULL
and	NULL
F	NULL
,	NULL
display	NULL
specific	NULL
interactions	NULL
with	NULL
proteins	NULL
that	NULL
are	NULL
present	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
and	NULL
unrelated	NULL
cells	NULL
as	NULL
well	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
the	NULL
sequence	NULL
corresponding	NULL
to	NULL
these	NULL
domains	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
homologies	NULL
with	NULL
known	NULL
sequences	NULL
,	NULL
except	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
hexamer	NULL
within	NULL
the	NULL
domain	NULL
F	NULL
,	NULL
with	NULL
the	NULL
sequence	NULL
5-TGGCTG-3	NULL
'	NULL
that	NULL
was	NULL
found	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
PF4	NULL
gene	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
anticipate	NULL
that	NULL
these	NULL
ubiquitous	NULL
factors	NULL
are	NULL
either	NULL
inactive	NULL
or	NULL
necessary	NULL
to	NULL
maintain	NULL
a	NULL
tissue-specific	NULL
DNA-protein	NULL
complex	NULL
.	NULL

Further	NULL
studies	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
these	NULL
factors	NULL
are	NULL
required	NULL
to	NULL
support	NULL
this	NULL
latter	NULL
hypothesis	NULL
.	NULL

Two	NULL
other	NULL
sites	NULL
interact	NULL
with	NULL
factors	NULL
that	NULL
are	NULL
only	NULL
present	NULL
in	NULL
megakaryocytes	NULL
or	NULL
megakaryocytic	NULL
cell	NULL
lines	NULL
.	NULL

A	NULL
binding	NULL
site	NULL
centered	NULL
at	NULL
position	NULL
-460	NULL
(	NULL
domain	NULL
D	NULL
)	NULL
formed	NULL
a	NULL
single	NULL
specific	NULL
DNA-protein	NULL
complex	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
this	NULL
domain	NULL
is	NULL
A-	NULL
and	NULL
T-rich	NULL
and	NULL
has	NULL
no	NULL
homology	NULL
with	NULL
any	NULL
other	NULL
sequences	NULL
from	NULL
megakaryocytic	NULL
genes	NULL
or	NULL
eukaryotic	NULL
genes	NULL
in	NULL
general	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
domain	NULL
E	NULL
contains	NULL
an	NULL
octamer	NULL
with	NULL
the	NULL
motif	NULL
5-CCTAGAAG-3	NULL
'	NULL
,	NULL
which	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
5	NULL
region	NULL
of	NULL
the	NULL
GPIb	NULL
gene	NULL
.	NULL

This	NULL
binding	NULL
site	NULL
is	NULL
located	NULL
at	NULL
position	NULL
-10	NULL
and	NULL
interacts	NULL
with	NULL
another	NULL
factor	NULL
only	NULL
present	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

These	NULL
two	NULL
domains	NULL
form	NULL
a	NULL
cluster	NULL
of	NULL
about	NULL
80	NULL
bp	NULL
,	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
necessary	NULL
to	NULL
confer	NULL
an	NULL
efficient	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
GPIIb	NULL
promoter	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
cluster	NULL
resulted	NULL
in	NULL
a	NULL
60	NULL
%	NULL
decrease	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
region	NULL
may	NULL
function	NULL
as	NULL
a	NULL
megakaryocyte-specific	NULL
enhancer	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
major	NULL
conclusion	NULL
of	NULL
this	NULL
study	NULL
is	NULL
that	NULL
the	NULL
GPIIb	NULL
promoter	NULL
region	NULL
contains	NULL
sufficient	NULL
information	NULL
to	NULL
direct	NULL
a	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
binding	NULL
sites	NULL
for	NULL
megakaryocyte-specific	NULL
nuclear	NULL
proteins	NULL
.	NULL

Functional	NULL
and	NULL
structural	NULL
characterization	NULL
of	NULL
these	NULL
proteins	NULL
will	NULL
constitute	NULL
the	NULL
next	NULL
step	NULL
to	NULL
verify	NULL
whether	NULL
they	NULL
represent	NULL
candidate	NULL
molecules	NULL
to	NULL
study	NULL
the	NULL
early	NULL
expression	NULL
of	NULL
megakaryocytic	NULL
genes	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
better	NULL
define	NULL
the	NULL
functions	NULL
of	NULL
the	NULL
different	NULL
GPIIb	NULL
regulatory	NULL
regions	NULL
and	NULL
to	NULL
verify	NULL
if	NULL
they	NULL
could	NULL
be	NULL
used	NULL
to	NULL
target	NULL
the	NULL
expression	NULL
of	NULL
heterologous	NULL
genes	NULL
in	NULL
the	NULL
megakaryocyte	NULL
in	NULL
vivo	NULL
.	NULL

Acknowledgments-We	NULL
gratefully	NULL
thank	NULL
Nancy	NULL
Trilhe	NULL
for	NULL
her	NULL
typ-ing	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
G.	NULL
Courtois	NULL
for	NULL
making	NULL
interesting	NULL
comments	NULL
and	NULL
Dr.	NULL
R.	NULL
Berthier	NULL
and	NULL
A.	NULL
Schweitzer	NULL
for	NULL
helping	NULL
us	NULL
with	NULL
megakaryocyte	NULL
cultures	NULL
.	NULL

REFERENCES	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
989	NULL
,	NULL
179-208	NULL
2	NULL
.	NULL

Berthier	NULL
,	NULL
R.	NULL
,	NULL
Marin	NULL
,	NULL
F.	NULL
,	NULL
Duperray	NULL
,	NULL
A.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Newton	NULL
,	NULL
L.	NULL
,	NULL
Schweitzer	NULL
,	NULL
A.	NULL
,	NULL
Hollard	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

(	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

15	NULL
,	NULL
750-758	NULL
3	NULL
.	NULL

Spangrude	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Heimfeld	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
I.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Sciences	NULL
(	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

241	NULL
,	NULL
58-62	NULL
4	NULL
.	NULL

Brandt	NULL
,	NULL
J.	NULL
,	NULL
Baird	NULL
,	NULL
N.	NULL
,	NULL
Lu	NULL
,	NULL
L.	NULL
,	NULL
Srour	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Hoffman	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

82	NULL
,	NULL
1017-1027	NULL
5	NULL
.	NULL

Martin	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1982	NULL
)	NULL
Science	NULL
216	NULL
,	NULL
1233-1235	NULL
6	NULL
.	NULL

Tabilio	NULL
,	NULL
A.	NULL
,	NULL
Ropa	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Nurden	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Del	NULL
Canizo	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Breton-Gorius	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Vainchencker	NULL
,	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

3	NULL
,	NULL
453-459	NULL
7	NULL
.	NULL

Seigneurin	NULL
,	NULL
D.	NULL
,	NULL
Champelorier	NULL
,	NULL
P.	NULL
,	NULL
Mouchiroud	NULL
,	NULL
G.	NULL
,	NULL
Berthier	NULL
,	NULL
R.	NULL
,	NULL
Leroux	NULL
,	NULL
D.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
McGregor	NULL
,	NULL
J.	NULL
,	NULL
Starck	NULL
,	NULL
J.	NULL
,	NULL
Morle	NULL
,	NULL
F.	NULL
,	NULL
Micoin	NULL
,	NULL
C.	NULL
,	NULL
Pietrantuono	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kolodie	NULL
,	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

(	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

15	NULL
,	NULL
822-832	NULL
8	NULL
.	NULL

Greenberg	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Rosenthal	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Greely	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Tantravahi	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Handin	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
1968-1977	NULL
9	NULL
.	NULL

Hynes	NULL
,	NULL
R.	NULL
O	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
549-554	NULL
10	NULL
.	NULL

Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Loftus	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Plow	NULL
,	NULL
E.	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
Thromb	NULL
.	NULL

Haemostasis	NULL
59	NULL
,	NULL
1-6	NULL
11	NULL
.	NULL

Plow	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Marguerie	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
in	NULL
Perspectives	NULL
in	NULL
Inflammation	NULL
,	NULL
Neoplasias	NULL
,	NULL
and	NULL
Vascular	NULL
Cell	NULL
Bioi-ogy	NULL
,	NULL
pp	NULL
.	NULL

267-275	NULL
,	NULL
Alan	NULL
R.	NULL
Liss	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
12	NULL
.	NULL

Phillips	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Charo	NULL
,	NULL
I.	NULL
F.	NULL
,	NULL
Parise	NULL
,	NULL
L.	NULL
V.	NULL
,	NULL
and	NULL
Fitzgerald	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Blood	NULL
71	NULL
,	NULL
831-843	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Expression	NULL
of	NULL
Platelet	NULL
GPIIb	NULL
Gene	NULL
Marguerie	NULL
,	NULL
G.	NULL
,	NULL
Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
Plow	NULL
,	NULL
E.	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
in	NULL
Platelets	NULL
in	NULL
Biology	NULL
and	NULL
Pathology	NULL
(	NULL
McIntyre	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Gordon	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

III	NULL
,	NULL
pp	NULL
.	NULL

85-125	NULL
,	NULL
Elsevier	NULL
Applied	NULL
Science	NULL
Publishers	NULL
Ltd.	NULL
,	NULL
Essex	NULL
,	NULL
United	NULL
Kingdom	NULL
Vinci	NULL
,	NULL
G.	NULL
,	NULL
Tabilio	NULL
,	NULL
A.	NULL
,	NULL
Deschamps	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Van	NULL
Haeke	NULL
,	NULL
D.	NULL
,	NULL
Henri	NULL
,	NULL
A.	NULL
,	NULL
Guichard	NULL
,	NULL
J.	NULL
,	NULL
Tetteroo	NULL
,	NULL
P.	NULL
,	NULL
Lansdorp	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Hercend	NULL
,	NULL
T.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Breton-Gorius	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

56	NULL
,	NULL
589-605	NULL
Fitzgerald	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Steiner	NULL
,	NULL
B.	NULL
,	NULL
Rall	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Jr.	NULL
,	NULL
Lo	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Phillips	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
3936-3939	NULL
Plow	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Loftus	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Levin	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
Fair	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Dixon	NULL
,	NULL
S.	NULL
,	NULL
Forsyth	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

83	NULL
,	NULL
6002-6006	NULL
Krissansen	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
Elliott	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Lucas	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Stomski	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
Berndt	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Cheresh	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Lopez	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
Burns	NULL
,	NULL
G.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
823-830	NULL
Pytela	NULL
,	NULL
R.	NULL
,	NULL
Pierchsbacker	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
Ruoslahti	NULL
,	NULL
E.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
5766-5770	NULL
Duperray	NULL
,	NULL
A.	NULL
,	NULL
Berthier	NULL
,	NULL
R.	NULL
,	NULL
Chagnon	NULL
,	NULL
E.	NULL
,	NULL
Ryckwaert	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Plow	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

104	NULL
,	NULL
1665-1673	NULL
Duperray	NULL
,	NULL
A.	NULL
,	NULL
Troesch	NULL
,	NULL
A.	NULL
,	NULL
Berthier	NULL
,	NULL
R.	NULL
,	NULL
Chagnon	NULL
,	NULL
E.	NULL
,	NULL
Frachet	NULL
,	NULL
P.	NULL
,	NULL
Uzan	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1603-1611	NULL
Rabellino	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Levene	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Leung	NULL
,	NULL
L.	NULL
L.	NULL
K.	NULL
,	NULL
and	NULL
Nachman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1981	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

154	NULL
,	NULL
88-100	NULL
Berridge	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Ralph	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Tan	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
Blood	NULL
66	NULL
,	NULL
76-85	NULL
Fraser	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Leahy	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Berridge	NULL
,	NULL
M.	NULL
V.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
68	NULL
,	NULL
762-769	NULL
Levene	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Lamaziere	NULL
,	NULL
J.	NULL
M.	NULL
D.	NULL
,	NULL
Broxmeyer	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Lu	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Rabellino	NULL
,	NULL
E.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

161	NULL
,	NULL
457-474	NULL
Kanz	NULL
,	NULL
L.	NULL
,	NULL
Mielke	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Frauser	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

(	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

16	NULL
,	NULL
741-747	NULL
Uzan	NULL
,	NULL
G.	NULL
,	NULL
Frachet	NULL
,	NULL
P.	NULL
,	NULL
Lajmanovich	NULL
,	NULL
A.	NULL
,	NULL
Prandini	NULL
,	NULL
M.-H.	NULL
,	NULL
Denarier	NULL
,	NULL
E.	NULL
,	NULL
Duperray	NULL
,	NULL
A.	NULL
,	NULL
Loftus	NULL
,	NULL
J.	NULL
,	NULL
Ginsberg	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Plow	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Kur	NULL
.	NULL

Biochem	NULL
.	NULL

171	NULL
,	NULL
87-93	NULL
Frachet	NULL
,	NULL
P.	NULL
,	NULL
Uzan	NULL
,	NULL
G.	NULL
,	NULL
Thevenon	NULL
,	NULL
D.	NULL
,	NULL
Denarier	NULL
,	NULL
E.	NULL
,	NULL
Prandini	NULL
,	NULL
M.-H.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Rep.	NULL
14	NULL
,	NULL
27-33	NULL
Prandini	NULL
,	NULL
M.~H	NULL
.	NULL

,	NULL
Denarier	NULL
,	NULL
E.	NULL
,	NULL
Frachet	NULL
,	NULL
P.	NULL
,	NULL
Uzan	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Marguerie	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

156	NULL
,	NULL
595-601	NULL
Heidenreich	NULL
,	NULL
R.	NULL
,	NULL
Eisman	NULL
,	NULL
R.	NULL
,	NULL
Surrey	NULL
,	NULL
S.	NULL
,	NULL
Delgrosso	NULL
,	NULL
K.	NULL
,	NULL
Bennett	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Schwartz	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Ponez	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Biochemistry	NULL
29	NULL
,	NULL
1232-1244	NULL
Van	NULL
Cong	NULL
,	NULL
N.	NULL
,	NULL
Uzan	NULL
,	NULL
G.	NULL
,	NULL
Gross	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Jegon-Faubert	NULL
,	NULL
C.	NULL
,	NULL
Frachet	NULL
,	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39.	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Schiitz	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
1311-	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

8939	NULL
P.	NULL
,	NULL
Boucheix	NULL
,	NULL
C.	NULL
,	NULL
Marguerie	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Frezal	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

80	NULL
,	NULL
389-392	NULL
Bray	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Rosa	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Lingappa	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
Kan	NULL
,	NULL
Y.	NULL
W.	NULL
,	NULL
McEver	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Shuman	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

80	NULL
,	NULL
1812-1817	NULL
Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Carthew	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
11-24	NULL
Courtois	NULL
,	NULL
G.	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Campbell	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Fourel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
688-692	NULL
Gidoni	NULL
,	NULL
D.	NULL
,	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
812	NULL
,	NULL
409-413	NULL
Plumb	NULL
,	NULL
M.	NULL
,	NULL
Frampton	NULL
,	NULL
J.	NULL
,	NULL
Wainwright	NULL
,	NULL
H.	NULL
,	NULL
Walker	NULL
,	NULL
M.	NULL
,	NULL
Macleod	NULL
,	NULL
K.	NULL
,	NULL
Goodwin	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Harrison	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
73-92	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Miller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Halligan	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
V.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
7019-7023	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
319	NULL
,	NULL
154-158	NULL
Ohlsson	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Edlund	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
35-44	NULL
1326	NULL
Chu	NULL
,	NULL
G.	NULL
,	NULL
Hayakawa	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Berg	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
1311-1326	NULL
Wigler	NULL
,	NULL
M.	NULL
,	NULL
Silverstein	NULL
,	NULL
S.	NULL
,	NULL
Lee	NULL
,	NULL
L.-S.	NULL
,	NULL
Pellicer	NULL
,	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
Cell	NULL
11	NULL
,	NULL
223-232	NULL
DeLuca	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McElroy	NULL
,	NULL
W.	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

123	NULL
,	NULL
764-770	NULL
Evans	NULL
,	NULL
T.	NULL
,	NULL
Reitman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A..	NULL
85	NULL
,	NULL
5976-5980	NULL
Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Martin	NULL
,	NULL
D.	NULL
I.	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
D'Andrea	NULL
,	NULL
A	NULL
,	NULL
D.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
839	NULL
,	NULL
446-451	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Eleouet	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Raichn	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Romeo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
6548-6552	NULL
Wenger	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Wicki	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
and	NULL
Clemetson	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

156	NULL
,	NULL
389-395	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
Greenberg	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Rosenberg	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
898-904	NULL
Lichtsteiner	NULL
,	NULL
S.	NULL
,	NULL
Wuarin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
963-973	NULL
Roméo	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Prandini	NULL
,	NULL
M.-H.	NULL
,	NULL
Joulin	NULL
,	NULL
V.	NULL
,	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Marguerie	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Uzan	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
447-449	NULL
Martin	NULL
,	NULL
I.	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Mutter	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
444-447	NULL

